Shiga Toxin-Producing Escherichia coli (STEC) Detection Strategies with Formalin-Fixed STEC Cells by Baker, Christopher Adam
University of Arkansas, Fayetteville
ScholarWorks@UARK
Theses and Dissertations
7-2015
Shiga Toxin-Producing Escherichia coli (STEC)
Detection Strategies with Formalin-Fixed STEC
Cells
Christopher Adam Baker
University of Arkansas, Fayetteville
Follow this and additional works at: http://scholarworks.uark.edu/etd
Part of the Animal Diseases Commons, Bacterial Infections and Mycoses Commons, and the
Food Microbiology Commons
This Thesis is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion in Theses and Dissertations by an
authorized administrator of ScholarWorks@UARK. For more information, please contact scholar@uark.edu, ccmiddle@uark.edu.
Recommended Citation
Baker, Christopher Adam, "Shiga Toxin-Producing Escherichia coli (STEC) Detection Strategies with Formalin-Fixed STEC Cells"
(2015). Theses and Dissertations. 1195.
http://scholarworks.uark.edu/etd/1195
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shiga Toxin-Producing Escherichia coli (STEC) Detection Strategies with Formalin-Fixed 
STEC Cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Shiga Toxin-Producing Escherichia coli (STEC) Detection Strategies with Formalin-Fixed 
STEC Cells 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of 
Master of Science in Food Science 
 
 
 
by 
 
 
 
Christopher Adam Baker 
University of Arkansas-Fort Smith 
Bachelor of Science in Biology, 2013 
 
 
 
 
 
 
July 2015 
University of Arkansas 
 
 
 
This thesis is approved for recommendation to the Graduate Council 
 
 
 
 
                                                                
Dr. Steven C. Ricke                             
Thesis Director 
 
 
 
 
 
 
                                                                                                                                        
Dr. Steven L. Foley    Dr. Jeffrey A. Lewis   
Committee Member    Committee Member 
 
  
Abstract 
Certain pathogenic Escherichia coli known as Shiga toxin (Stx)-producing Escherichia 
coli (STEC) are commensals in cattle, and typically cause bloody diarrhea in humans once the 
Stx toxin is secreted in invaded intestinal epithelial cells. Infections with STEC cells can lead to 
hemolytic uremic syndrome, which is commonly associated with kidney failure. Several STEC 
serogroups have been declared adulterants in raw, non-intact ground meat, and future regulations 
could potentially lead to a higher number of STEC serogroup detection strategies for these 
pathogenic microorganisms. Microbiological research laboratories may benefit from formalin-
fixed STEC cells for periodic (daily, weekly, monthly, among others) instrument 
validation/calibration by serving as a working set of known cell concentration samples and 
internal standard i.e. positive control. These cell concentrations may be used across laboratories 
in different geographical locations, within an individual laboratory, and across a broad range of 
detection assays (molecular as well as immuno-based). This thesis consists of three research 
parts: a comprehensive literature review that covers STEC incidence in foods and molecular 
detection techniques (chapter 1), a literature review that covers immuno-based detection 
strategies (chapter 2), and a research manuscript that involves the development of an internal 
standard and positive control with formalin-fixed STEC cells that can be used for a broad range 
of molecular as well immuno-based detection assays for instrument calibration and validation 
purposes (chapter 3). 
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I. Introduction 
This thesis focuses on molecular and immuno-based detection strategies for Shiga toxin-
producing Escherichia coli (STEC). Although each article focuses on different facets of STEC, 
the common theme throughout these three chapters is the advantages and limitations of STEC 
detection methods, and future strategies for improvement of various detection methods. 
Commensal Escherichia coli are commonly utilized for investigating the genetic and 
biochemical requirements of microorganisms, and have served in a wide variety of applications. 
Certain pathogenic Escherichia coli known as STEC are a public health threat to the consumer, 
and are problematic for the food industry. Food products containing STEC are deemed unfit for 
human consumption, and STEC illnesses can cause hemolytic uremic syndrome (HUS), a disease 
affecting the kidneys in susceptible individuals. These pathogens are present in a wide range of 
environments, and have caused numerous foodborne outbreaks and recalls. These outbreaks and 
the increased awareness of STEC have led to certain STEC serotypes to be declared adulterants 
in non-intact raw meat. Various STEC detection methods have been investigated, and numerous 
cultural and molecular-based detection methods continue to be modified to meet regulatory 
requirements. However, STEC serotypes may possess certain characteristics that lead to bias in 
the likelihood of a certain serotype being detected in an assay. Understanding the components of 
these STEC serotypes will provide means for optimizing the detection platforms, and as a result 
limit foodborne illness and recalls caused by STEC due to enhanced cultural and molecular 
detection capabilities. Research aspects of this thesis focus on an internal standard i.e. positive 
control (formalin-fixed STEC cells) that can complement commercial detection assay kits for 
instrument calibration and validation. 
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Introduction 
Escherichia coli isolates are characterized as Gram negative, chemoorganotrophic, 
oxidase negative commensal microorganisms that are 1.1 to 1.5 µm in diameter, and 2 to 6 µm in 
length (Brenner et al., 2005). As a member of the Enterobacteriaceae family, E. coli in general 
contain between 48.5 to 52.1 percent guanine-cytosine in their DNA (Brenner et al., 2005). 
Escherichia coli can be isolated from humans and numerous animal hosts, and occur throughout 
most of the gastrointestinal tract. These microorganisms can grow within a pH range of 5 to 9 
(Zilberstein et al., 1984), but can survive after a short exposure to a pH level as low as 2 (Small 
et al., 1994), which is required if they are to successfully pass through the acidic stomach 
environment prior to intestinal colonization. 
Historically, commensal E. coli have been among some of the most thoroughly studied 
microorganisms in the biological sciences and have served as the basis for understanding many 
of the fundamental genetic and biochemical concepts (Koch and Schaechter, 1984; Sofos and 
Smith, 1993; Alteri and Mobley, 2012). Not surprisingly, E. coli offer tremendous utility for a 
wide range of applications due to their well-characterized genome (Souza et al., 2002; Kang et 
al., 2004; Baba et al., 2006; Lajoie et al., 2013). Since complex preformed organic molecules are 
generally not required by E. coli for growth (Koch and Schaechter, 1984), this biosynthetic 
capacity has been exploited for numerous genetic engineering applications. Consequently, E. coli 
strains have been employed as genetic engineering platforms for heterologous protein production 
(Richins et al., 1997; Terpe, 2006), biosensor development (Ryabova et al., 2008; Chalova et al., 
2009, 2010; Potera, 2013), and indicator probes (Cha et al., 2000; Guido et al., 2006; Sanchez 
and Golding, 2013). More recently, progress has been made toward E. coli genome 
reconstruction to generate strains that can be used to monitor the intestinal tract by recognizing 
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metabolites characteristic of human disease, which could be applicable in diagnosis and therapy 
(Kotula et al., 2014). This in turn has implications for adjusting the molecular framework to 
regulate the gut microbiota that would potentially provide a more accurate model of the human 
gut-microorganism relationship (Koli et al., 2011).  
Pathogenic E. coli have been identified as the leading cause of traveller’s diarrhea (40 to 
70% of reported cases), and as the name implies, most often occurs when humans consume 
contaminated food during their travels to less developed countries (Rowe et al., 1970; Cook, 
1983; Sofos and Smith, 1993). The term Shiga toxin (Stx)-producing E. coli (STEC) was 
adopted due to the similarity of the toxin generated by the stx1 gene to the Stx produced by 
Shigella dysenteriae (O’Brien et al., 1984; Lingwood, 1999). In addition to Stx1, STEC may 
possess the Stx2 toxin as well as various Stx1 and/or Stx2 variants (Oku et al., 1989; Willford et 
al., 2009; Skinner et al., 2013). STEC possess an eae gene that codes for intimin, a 94- to 97-kDa 
attachment and adhesion outer membrane protein, which enables the bacterium to invade the 
intestinal wall of a host (Nataro and Kaper, 1998; Spears et al., 2006). Upon invasion, Stxs are 
subsequently released and can cause life-threatening health complications. People that are 
immunocompromised, including infants and the elderly, are considered to be at the greatest risk 
to STEC (Boyce et al., 1995; Westerholt et al., 2003). 
A major public health concern is the possibility of STEC infections becoming a more 
severe form of clinical disease classified as hemolytic uremic syndrome (HUS), which typically 
occurs in roughly 5% of the reported cases (Tuttle et al., 1999) 3 days after the onset of diarrhea 
(Karmali et al., 1985). The mortality rate of HUS illnesses is roughly 5% (Kaplan et al., 1998; 
Razzaq, 2006) although rates are higher in developing countries where most cases are not treated 
(Rivas et al., 2008; Heuvelink et al., 2002). This is likely due to the lack of resources. The 
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specific details of the onset, pathogenesis, and methods to treat HUS have been extensively 
reviewed elsewhere (Kaplan et al., 1998; Tarr et al., 2005; Welingder-Olsson and Kaijser 2005; 
Spears et al., 2006; Mayer et al., 2012). The objective of this review is to address the factors that 
impact the incidence of STEC as well as the procedures currently implemented for STEC 
detection in food. 
 
STEC sources 
Environmental – Animal reservoirs 
Domestic and wild animals are a major source of STEC, which are often associated with 
cattle as well as corresponding environmental niche(s) contaminated with fecal matter. Animal 
reservoirs often lack clinical signs of disease, which makes the reduction and prevention of 
contamination a challenge. Animals originating from farms, slaughterhouses, county livestock 
fairs, and petting zoos are known to be sources of STEC (Varma et al., 2003). Petting zoos pose 
a particular problem (especially for children) due to close contact during the petting and feeding 
of possibly STEC-ridden animals that lack clinical signs of disease (Heuvelink et al., 2002). 
Atypical environments prone to fecal contamination are largely associated with cross 
contamination due to human error (Jones 1998; Fonesca and Ravishankar, 2007). Persons 
exposed to areas highly associated with STEC have been encouraged to be aware of possible 
risks in these types of environments (CDC, 2012).  
A major contributor in animal-to-animal transmission is the high population levels of 
STEC that can be present in cattle feces. Cattle that shed feces highly concentrated in STEC 
(greater than 104 colony forming units (CFU)/g) have been termed super shedders (Arthur et al., 
2009, 2010). Even in cattle feedlots with only a minimal amount of STEC carrying cattle, the 
  
6
presence of just a few super shedders can result in widespread transmission and contamination. 
In one study, 96 % of all E. coli O157:H7 shed by a group of cattle were linked to only 9 % of 
the cattle (Omisakin et al., 2003). However, it is unknown whether this phenomenon only 
pertains to a portion of cattle or if all cattle transition into super shedders following STEC 
infection (Smith, 2014). 
Although hides are considered a major contributor to carcass contamination (Schmidt et 
al., 2012), the actual role of hides in STEC contamination is a controversial topic as swabbing 
techniques and the location(s) on the hides that are swabbed can lead to inconsistent recoveries 
of STEC (Elder et al., 2000). This in turn can result in less than certain attributes for the role of 
hides in carcass contamination (Elder et al., 2000; Arthur et al., 2009). More incidences of STEC 
illnesses occur during the summer months (Banatvala et al., 2001) most likely due to the higher 
loads of pathogenic E. coli shed by cattle during this time, which leads to hide and eventual 
carcass contamination during processing (Elder et al., 2000). 
The various cattle diets and management practices among feedlots should be considered 
when comparing data, and determining the efficiencies of management practices is problematic 
in that the cattle population density, season, and geographic locations in which the corresponding 
studies were conducted are all likely contributors to contrasting results and varying conclusions 
(Dargatz et al., 1997; Callaway et al., 2003). Various pre-harvest management practices to 
reduce STEC shedding and hide contamination are available (Callaway et al., 2004), but variable 
results on the efficacy of prevention measures make implementing the best management 
strategies a difficult task (Callaway et al., 2003). 
Numerous investigations have supported the suggestion that grain-fed cattle typically 
shed higher levels of E. coli when compared to forage-fed cattle (Callaway et al., 2009). Diez-
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Gonzalez et al., (1998) observed higher numbers of E. coli in the feces of cattle that were fed 
diets consisting of higher amounts of grain. Additionally, when cattle diets were switched from a 
90% grain diet to a hay diet, these authors observed nearly 106 fold fewer E. coli after only five 
days from the diet alteration (Diez-Gonzalez et al., 1998). They also concluded that grain was 
more efficient with regard to cattle performance, and that strictly forage-based diets were 
unlikely to become commonplace in American cattle feed. However, they suggested that 
switching from a grain to forage diet prior to slaughter could potentially limit E. coli 
transmission from farm-to-slaughter (Diez-Gonzalez et al., 1998). 
Following their research on the influence of diets and the prevalence of E. coli O157:H7 
in sheep, Kudva et al., (1997) suggested that ruminants fed a grain based diet exhibited less E. 
coli O157:H7 shedding compared to ruminants fed a forage based diet. These authors also 
suggested that dietary changes could create a more favorable environment for E. coli O157:H7 in 
ruminants (Kudva et al., 1997), while Hovde et al., (1999) observed differences in the duration of 
STEC shedding by cattle fed grain and forage based diets. E. coli O157:H7 (1010 CFU) was 
administered into the rumen of cattle via a gastric tube, and these cattle were fed either grain or 
forage based diets. Fresh fecal samples were obtained every 3 to 4 days, and cultured for E. coli 
O157:H7. These authors were able to culture E. coli O157:H7 from forage fed cattle roughly 10 
times longer than grain fed cattle – forage fed cattle contained E. coli O157:H7 for an average of 
39 days (alfalfa hay) and an average of 42 days (grass hay), while grain fed cattle contained E. 
coli O157:H7 for an average of only 4 days (Hovde et al., 1999). Additionally, unlike Diez-
Gonzalez et al., (1998) observations on increased recovery of acid-resistant E. coli from grain 
fed cattle, these authors found no differences in acid resistance of E. coli O157:H7 fed grain and 
forage based diets (Hovde et al., 1999). These contrasting results of E. coli and STEC levels in 
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grain or forage fed cattle could be due to varying sampling methods, the type of ruminant used 
for the research, and the geographic distribution of these ruminants.  
The presence of litter material, hay, silage, fur, and feathers contributes to the prevalence 
of microorganisms in feedlots and animal housing, and it has been suggested that airborne 
transmission of STEC is possible (Al-Dagal and Fung, 1990; Zucker et al., 2000; Wilson et al., 
2002; Pillai and Ricke, 2002; Varma et al., 2003; Lues et al., 2007; Patel and Nou, 2008; Martin 
et al., 2010). In addition to areas highly concentrated with livestock, a drier and warmer 
environment may also contribute to an increase in airborne transmission (Lutgring et al., 1997; 
Wilson et al., 2002). Likewise, the hide, skin, and carcass of slaughtered animals can be a major 
source of airborne microorganisms in processing plants (Rahkio and Korkeala, 1997; Ahmed and 
Sarangi, 2013). The direction of airflow influences airborne transmission (Rahkio and Korkeala, 
1997; Cundith et al., 2002), and birds and insects can also act as vectors. In addition to 
distributing urine and feces, the aerosols they generate contain airborne microbial populations 
including pathogens (Hugh-Jones and Wright, 1970). 
By considering the possibility of airborne transmission, it has been recommended that 
processing plants should be designed to consistently direct airflow from finished product(s) to 
raw materials (Lutgring et al., 1997). Additional prevention strategies include locating air filters 
as close as possible to the contamination source, using “clean room clothing” (head covering, 
masks, gloves, among others) (Al-Dagal and Fung, 1990), proper maintenance of ventilation 
systems (Lutgring et al., 1997), and implementing air cleaning systems (Cundith et al., 2002). 
The possibility of contamination by airborne microorganisms is often overlooked, and since a 
low infectious dose of STEC may lead to infection (it has been estimated an infectious dose of E. 
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coli O157:H7 ranges from 10 to 100 cells (Feng et al., 2011)), airborne transmission may be 
more of a concern for STEC compared to other less infectious pathogens. 
 
Human-to-human transmission 
Bacterial transmission occurs among humans, as well as from contaminated food and 
water (Keene et al., 1994; Islam et al., 2004; Fonesca and Ravishankar, 2007; Fischer et al., 
2007; Craun et al., 2010). The original sources for STEC are likely to be cattle or human carriers 
(Wang and Doyle, 1998; Council for Agricultural Science and Technology, 2004). Nursing home 
outbreaks have been documented (Ryan et al., 1986; Carter et al., 1987) and nursing home safety 
awareness and regulatory measures are usually addressed (Rangel et al., 2005), but more needs 
to be done. For instance, improvements for infection control procedures are needed. This would 
include constant surveillance of the elderly and their dining facilities before, during, and after 
food consumption to reduce cross-contamination and illness, and any ill individuals should be 
isolated to prevent spread among nursing homes. Also, proper food preparation practices, eating 
habits, hygiene, and thoroughly cooking food are all considered effective means for preventing 
an outbreak in these types of environments (Ryan et al., 1986; Thoreau, 1986; Carter et al., 1987; 
Rangel et al., 2005). 
Day-care facilities are also a high-risk environment for STEC infection. Greater infection 
rates are probably a consequence of children’s behavioral patterns. Children more frequently 
place their hands in their mouth and are more likely to not wash their hands (Black et al., 2005). 
In addition, young children are less likely to be trained to use the restroom properly (Belongia et 
al., 1993). Occurrence of STEC illnesses have been linked to improperly chlorinated swimming 
pools (usually attributed to infants swimming in diapers) (Friedman et al., 1999), but identifying 
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a body of water as a source of contamination can be difficult. Water sources typically contain 
minimal or no nutrients, which can physiologically stress microorganisms and subsequently 
cause metabolic and morphological alterations. 
Physiologically stressed STEC may be particularly problematic as cells in this state can 
be difficult to recover and detect. This is in part due to the fact that microorganisms that are 
exposed to a stressful environment can enter a survival state that has been defined as viable but 
nonculturable (VBNC) (Binsztein et al., 2004). Although cellular energy levels remain constant 
(Beumer et al., 1992), a reduction of nutrient transport, respiration, and macromolecular 
synthesis has been observed in VBNC cells (Oliver 2000, 2005). Also, Gram-negative bacteria 
can become reduced in size, and exhibit a more rounded morphology compared to cells in a more 
favorable growth environment (Rollins and Colwell 1986; Donelli et al., 1998; Signoretto et al., 
2000). 
Viable but nonculturable cells are troublesome in that they are not identifiable on 
conventional culture media, and can lead to false conclusions about the true population of cells in 
an environment. Also, E. coli that become VBNC pose a problem for assessing water quality 
since they are often the primary microorganisms used to indicate the fecal contamination level in 
water systems (Edberg et al., 2000; Oliver et al., 2005). The inability to culture VBNC cells 
leads to the possibility of underestimating, as well as not detecting these cells, and VBNC 
pathogenic microorganisms in food systems present a potential public health threat (Oliver et al., 
2005). 
 
Food sources 
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The public’s lack of knowledge on proper food safety practices has been identified as a 
contributing factor to STEC outbreaks (Roseman and Kurzynske, 2006; Rivas et al., 2008). 
Consequently, it should be fairly well established from a public sector standpoint that any food 
has the potential to be unsafe due to contact with STEC, whether it occurs by human error or 
during production, processing, shipping, storage, or cooking. Food safety public awareness and 
control measures must be continually addressed to reduce and limit STEC. Proper hand washing, 
preventing cross-contamination while preparing food, storage of meat below 40 °F (4.4 °C), and 
using a thermometer to confirm an internal temperature of 160°F (71 °C) during cooking are 
considered necessary steps to take for preventing foodborne illnesses (Vogt and Dippold, 2005; 
FSIS, 2011). 
As discussed previously, pathogen prevention measures (drastic pH changes, heat 
exposure, among others) during food processing can cause bacteria to become VBNC (Shen et 
al., 2009; Díaz et al., 2010). Stressed and damaged cells may not be identifiable when cultured, 
but may later resuscitate and subsequently proliferate (Hussong et al., 1987), which can result in 
an underestimation of the original levels of microorganisms present while being enumerated. The 
fact that microorganisms can adapt, survive, regrow, and disperse in various environments makes 
preventing contamination and illness a difficult task. Theoretically, even if quality assurance and 
control procedures are appropriately in place, illnesses and outbreaks can occur, and based on 
past experiences, an end to such occurrences does not seem likely.  
Some specific instances of food preparation or lack thereof can also contribute to STEC 
occurrence. For example, raw milk consumption has recently become popular (Houser et al., 
2008; Baylis, 2009; Claeys et al., 2013, 2014). It has been estimated that three percent of the 
U.S. population consumes raw milk each week (CDC, 2007a). Milk is rich in nutrients, and has a 
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neutral pH, which is favorable for bacterial survival and growth (Lejeune and Rajala-Schultz, 
2009). Not surprisingly, raw milk has been identified as a source of STEC contamination, and 
the potential public health consequence(s) of consuming raw milk have been reviewed (Oliver et 
al., 2009). From 1973 to 1992, 1733 cases of infection were reported due to raw milk 
consumption. Of these cases, 6 were identified as being caused by E. coli O157:H7 and the 
source of 281 cases was declared unknown (Headrick et al., 1998). Conceivably, STEC 
contamination could have been the cause of many of the unknown cases. Milk contamination is 
likely due to cross-contamination of feces during or after the milking process (Heuvelink et al., 
1998). It is becoming apparent that additional safety procedures should be addressed on dairy 
farms where raw milk is produced for retail to limit contamination. The CDC lists several ways 
in which pathogens can contaminate milk such as cattle feces, cattle udder infection (mastitis), 
processing equipment, insects and rodents, and humans from contaminated clothing and boots 
(CDC, 2014). With all of the numerous potential pathogen sources, it seems that appropriate 
safety procedures should include cross-contamination prevention measures, and continuous 
assessment of cattle udder health, equipment, milk collection areas, and human garment 
cleanliness. 
For conventional milk production, pasteurization involves eliminating pathogens that 
may be present in raw milk by heat exposure for a short period of time (Oliver et al., 2009). The 
USDA recommends that the pasteurization process should be performed at one of three 
conditions: 63 ºC for 30 minutes, 72 ºC for 15 seconds, or 89 ºC for 1 second (Rasooly and Do, 
2010). Assessing the most safe milk pasteurization temperature(s) can be difficult; Stasiewcz et 
al., (2014) found that increasing the temperature from 72 ºC to 82 ºC for 25 seconds increased 
the total population of Listeria monocytogenes in milk. The authors hypothesized that the 
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inactivation of lactoperoxidase at 82 ºC, an enzyme in milk that is bacteriostatic and 
bacteriocidical, was the cause of an increase in L. monocytogenes (Stasiewicz et al., 2014). 
D’Aoust et al., (1988) investigated the survivability of E. coli O157:H7 in milk following 
pasteurization at temperature ranges of 60 ºC to 72 ºC for 16.2 seconds for each temperature 
tested. There was a 4-log reduction of E. coli O157:H7 at 63 ºC for 16.2 seconds, but only 
temperatures of 64.5 ºC and higher for 16.2 seconds were sufficient in deactivating all E. coli 
O157:H7 in milk (D’Aoust et al., 1988). Although this study identified which pasteurization 
temperatures would effectively inactivate E. coli O157:H7, direct plating techniques were used 
to determine the presence of E. coli O157:H7 in the pasteurized milk samples. Using a plating 
method may not have necessarily given a true indication of the present bacterial populations due 
to the possibility of VBNC cells that could have formed during the pasteurization process. 
While E. coli O157:H7 was inactivated at temperatures exceeding 64.5 ºC, milk 
containing high levels of STEC that produced large amounts of Stx toxin before pasteurization 
could still cause illness. Rasooly and Do (2010) investigated how Stx2 toxin survives the various 
USDA pasteurization recommendations. These authors justified investigating the effects of 
pasteurization on the Stx2 toxin rather than Stx1 because of a previous study where Tesh et al., 
(1993) had demonstrated that Stx2 was 400 times more virulent to mice than the Stx1 toxin 
(Tesh et al., 1993; Rasooly and Do, 2010). Rasooly and Do (2010) concluded that neither of the 
USDA recommended pasteurization conditions were sufficient to eliminate Stx2 toxin, which 
was only inactivated following pasteurization for 5 minutes at 100 ºC. This study was useful in 
providing insight into the stability of Stx2 in conventional pasteurization temperatures, but the 
effect that these conditions have on STEC was not addressed. Unless a large number of STEC 
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(that have produced a substantial amount of Stx(s)) are present in the raw milk before 
pasteurization, eliminating STEC by pasteurization should be sufficient to ensure safe milk. 
There will always be the threat of contamination of milk during the production process 
whether it be during raw milk production or after pasteurized milk has been heat treated (Oliver 
et al., 2009). Although heat treatment is still the best strategy to eliminate pathogens in milk, 
options for raw milk are much more limited. Therefore, control measures such as washing udders 
prior to milking would represent a possible means to limit contamination and therefore reduce 
illnesses within production parameters specified for raw milk (Baylis, 2009).  
In the U.S., the most common food associated with STEC infections is improperly 
cooked ground beef (Boyce et al., 1995; Razzaq, 2006). Carcass contamination by feces during 
processing may be unavoidable, and STEC growth may occur following production. It has been 
suggested that the meat matrix (pH, percent sodium chloride, water activity among others), as 
well as the exposure and duration of temperature fluctuations during food processing, 
transportation, distribution, and storage (as well as a number of other factors) may contribute to 
STEC growth in ground beef (Walls and Scott, 1996; Cassin et al., 1998; Juneja et al., 1998; 
Ansay et al., 1999).  
The sources and origins of ground beef partially accounts for the high risk of STEC 
contamination since ground beef is typically made from the trimmings of more than one carcass, 
thus increasing the likelihood of STEC contamination through multiple sources (Armstrong et 
al., 1996). Also, since ground beef is composed of many small meat particles, the product as a 
whole represents a large surface area, and is further troublesome in that the ground beef is more 
prone to STEC exposure due to contaminated surfaces, tools, and machinery (Surkiewicz et al., 
1975; Pillai and Ricke, 1995; Schroeder et al., 2003). Additionally, the large surface area of 
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ground beef favors rapid bacterial growth by providing an aerobic environment for 
microorganisms to proliferate (Pohlman et al., 2002). The doubling time of E. coli is roughly 20 
minutes under aerobic conditions, but in a study comparing the effect of media on growth rates, a 
doubling time as high as 16.8 minutes has been observed (Guerini et al., 2006). Theoretically, if 
a single STEC cell comes into contact with a food product at 8 am, and subsequently doubled in 
population every 20 minutes, there would be over 1000 STEC cells in the food product by 11:40 
am (within 3 hours, 40 min). These circumstances are based on the assumption that the food 
product provided sufficient growth conditions (excluding refrigerated or frozen ground beef) 
comparable to broth-based culture conditions. With many animal sources, the potential for cross-
contamination, and foods that are favorable to proliferation, STEC continues to be a major cause 
of foodborne illness and subsequent outbreaks (Hussein, 2007). Previous outbreaks associated 
with STEC were instrumental in the restructuring of how food safety analyses are conducted in 
the U.S. meat industry. 
 
Epidemiology in the U.S. 
The annual number of foodborne illnesses (Scallan et al., 2011), as well as the costs of 
these illnesses (Scharff, 2012) in the U.S. have been estimated (Table 1). Similar to many 
foodborne illnesses, the prevalence of STEC infection is likely underestimated for a variety of 
reasons (Wickham et al., 2006). For example, not all clinical laboratories have the means to 
screen fecal samples for STEC, resulting in fewer confirmed reported cases. Underestimation is 
also caused by incidences where individuals despite contracting STEC do not seek medical 
treatment due to mild symptoms and thus remain unreported.  
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It has been estimated that bacterial agents in beef products caused 482,199 illnesses; 2650 
hospitalizations and 51 deaths annually in the U.S. from 1998 to 2008 (Painter et al., 2013). 
Although foodborne illnesses occur more often with pathogens other than STEC, STEC are still 
considered a major risk to public health due to the very low doses required to cause an infection 
(Bell et al., 1994; Rowe et al., 1994; Ray and Bhunia, 2014); bacterial populations ranging from 
10 to 100 E. coli O157:H7 cells are known to cause human illness (Feng et al., 2011). 
 
STEC publicity and government action – A history of the U.S. experience 
The first fully documented modern outbreak of STEC occurred in the early summer of 
1982 (Riley et al., 1983). Illnesses and outbreaks continued throughout several countries for the 
next ten years (Karch et al., 1999; Rangel et al., 2005). It was not until the northwestern U.S. 
retail restaurant associated outbreak of 1992-1993 that public awareness and eventual 
government action spawned a general alarm and mobilized a comprehensive regulatory response 
to STEC (Schuller, 1998). During the course of this outbreak, foodborne illnesses caused by E. 
coli O157:H7 were reported in Washington, Idaho, Nevada, and California (Karch et al., 1999). 
Eighty-six percent of the cases were reported from the state of Washington and thus historically 
became identified as the “Washington experience” (Bell et al., 1994). This outbreak was traced 
to a single fast food chain that did not thoroughly cook hamburger patties, which led to 731 
confirmed cases, 170 hospitalizations, 56 cases of HUS and the death of four children. Given the 
extent of the outbreak and the severity of the ensuing illness, it soon became apparent that the 
infectious agent involved had possessed considerable virulence potency that would be consistent 
with a low infectious dose. Consequently, not only did identifying the organism become 
important, but quantifying actual levels of the pathogen came to be considered equally critical. 
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Therefore, as part of the outbreak investigation, bacteria from frozen hamburger patty samples 
were enumerated to determine the amount of E. coli O157:H7 originating from individual 
patties. 
This outbreak shed additional light on the lethal potential of STEC and the need for 
comprehensive and systematic control of this pathogen in ground beef in the U.S. in the mid-
1990’s. In response to national publicity and ensuing public concerns, regulatory action became 
a focal point for additional control measures to be taken, and publicity of the subsequent 
outbreak led to changes in the meat industry (Bottemiller, 2011). Following the U.S. Secretary of 
Agriculture’s involvement in addressing the outbreak, more meat inspectors were hired and 
recall notification requirements were improved (Bottemiller, 2011). Also, in response to the 
well-publicized outcry, the U.S. Department of Agriculture (USDA)-Food Safety and Inspection 
Services (FSIS) adopted the zero-tolerance policy for visibly contaminated meat during 
processing (Kochevar et al., 1997).  
Consequently, the USDA Deputy Commissioner for Policy at the time, led a strategic 
effort among agency legal counsel and research personnel to initiate a case for E. coli O157:H7 
to be classified as an adulterant under the Federal Meat Inspection Act (FMIA) (Bottemiller, 
2011). On September 29, 1994, Mike Taylor spoke at the American Meat Institute’s annual 
convention and addressed the plan to consider E. coli O157:H7 as an adulterant (Bottemiller, 
2011). This promptly spread controversy in the meat industry, and on December 13, 1994, 
several supermarket and meat industry organizations filed a legal suit against the USDA and 
stated the E. coli O157:H7 adulterant statute violated the Administrative Procedure Act and was 
outside the realm of the USDA’s authority under the FMIA, but the Federal District Court upheld 
the USDA’s official decision (Bottemiller, 2011). 
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Once adulterant status was established, the need for sensitive detection strategies became 
obvious and thus immediately impacted and accelerated the search for even faster and more 
sensitive detection systems. Several costly recalls followed (Table 2) (Schuller, 1998), and it 
became clear in the U.S. that detection capabilities would need to be vastly improved both in 
terms of speed and accuracy. One of the primary lessons that was learned from establishing the 
adulterant status was not just the need for sensitivity improvement but for more consistent and 
reliable detection technologies. Correctly identifying and classifying STEC each and every time 
as rapidly as possible was projected as a means to theoretically minimize illnesses during 
outbreaks as well as improve the treatment of infections and overall public health (Sobel et al., 
2002). Aside from health costs directly due to illnesses, the issues of recalls, unused products, 
and possible lawsuits from undetected STEC continues to be an ongoing economic concern in 
the food industry. Contaminated products are not only a public health threat to the consumer but 
a potential economic disaster for the processor both in terms of loss of product and negative 
publicity –not to mention the potentially extensive litigation costs. For example, the Washington 
state experience in 1992-1993 led to several settlements in favor of the victims of the outbreak, 
and the largest settlement ($15.6 million) went to a victim who spent 42 days in a coma 
(Schuller, 1998). Since then, STEC-associated foodborne outbreaks have been and continue to be 
a significant threat to public health and food industry economics. 
 
Non-O157 STEC in the U.S. 
Several pathogenic E. coli outbreaks not associated with E. coli O157 were documented 
following the Washington state experience (Brooks et al., 2005). Not surprisingly, as improved 
methods to identify non-O157 STEC surfaced, there was a four-fold increase in reports of non-
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O157 illnesses from 2000 to 2006 (Windham et al., 2013) and awareness of these pathogenic 
serovars increased. On October 5, 2009, a citizens petition was filed to suggest non-O157 STEC 
also be considered adulterants (Clark, 2009), and in 2011 the FSIS declared six additional STEC 
(O26, O45, O103, O111, O121 and O145), alongside E. coli O157 as adulterants in raw, non-
intact ground beef products (FSIS, 2011; Fratamico and Bagi, 2012). 
Protocols for the detection of non-O157 STEC continue to be investigated (Hegde et al., 
2012a, 2012b; Cowan-Lincoln, 2013) with the ultimate goal of devising and/or implementing 
new technologies and/or combining methods to optimize and exceed performance standards of 
the industry (Wang et al., 2013). Methods that rapidly produce the most reliable and consistent 
results represent the ultimate goal. Rapid detection has been defined as less than 12 hours 
(Guerini et al., 2006), and it has been suggested an 8 hour time period from initiation to 
reportable results would be optimal due to the fact that an 8-hour detection time would produce 
results on a set of food products before being shipped from a production facility (Cox, 1988; 
Gooding and Choudary, 1997, 1998; Guerini et al., 2006; Hagren et al., 2008; Wilkes et al., 
2012). Much of this emphasis is due to the current requirement by USDA-FSIS for STEC test 
and hold of meat products prior to release in the commercial retail sector. Test and hold involves 
sampling ground beef or trim for adulterants. Trim is typically used to produce ground beef and 
is defined as the outer portions of the beef carcass that is removed from meat to make the prime 
cuts that are more commercially desirable (Smith, 2012). Acceptable products can be released 
into commerce distribution routes once the product sample test outcomes are confirmed negative 
for STEC (Guerini et al., 2006). In a two day time frame, product(s) can be confirmed as 
acceptable, and in four days product(s) can be confirmed as unacceptable following culture 
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confirmation (FSIS, 2013a). It should be noted that these time frames do not include the 12 to 24 
hour minimum to freeze samples prior to transportation to a laboratory (FSIS, 2013a). 
 
STEC growth enrichment approaches for detection 
General concepts 
For most foodborne pathogens, the frequency and total numbers of microorganisms on a 
particular food product are relatively low. This represents a challenge for detection since 
sampling protocols need to be designed to account for infrequent and non-uniform distributions 
of a pathogen and relatively low population numbers. Consequently, most detection methods 
include steps to increase (enrich) the initial number of the target pathogen to population levels 
for consistent and reliable detection. Thus, the first step for STEC detection is to enrich the 
sample to be analyzed. Several factors contribute to the type of enrichment procedure utilized: 
the sensitivity of the particular detection technology (Woo and Palavecino, 2013), level and 
complexity of background microflora (Vimont et al., 2006), and the presence of interfering 
substrates associated with the food matrix that would either inhibit STEC growth or interfere 
with the detection system output (Maciorowski et al., 2005). Enrichment media vary in 
composition but generally provide an environment appropriate to increase a bacterial cell 
population. Such constituents provide a supportive nutritional matrix for growth of 
microorganisms, or in the case of a selective enrichment medium, a particular segment of the 
bacterial population (Holt and Krieg, 1994). 
To identify STEC, enrichment and culture media that are best suited to optimally support 
the growth physiology of all STEC requires an understanding of the metabolism of the organism. 
The specific biochemical growth limitations of STEC and generic E. coli have been described 
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(Atkinson et al., 2012), and efficient enrichment and culturing media containing various 
components to grow STEC have been reported in a series of publications over a number of years 
(Doyle and Schoeni, 1984; Wallace and Jone, 1996; McCarthy et al., 1998; Taormina et al., 
1998; Vimont et al., 2006; Guerini et al., 2006) and have been reviewed previously (De Boer and 
Heuvelink, 2000). As would be expected, there are many factors that affect growth of STEC 
bacteria (Table 3). Although STEC can grow in various conditions, providing an environment 
with appropriate concentrations of required nutrients, a pH range of 6.5 to 7.5, and an adequate 
volume of enrichment culture are considered generally necessary to achieve optimal growth 
(Greasham and Herber, 1997). 
In addition to decreasing detection time, analysis of media efficiency using smaller 
quantities and/or aliquots could reduce the cost, time, and required laboratory incubation space 
for the enrichment process (Guerini et al., 2006). When reducing the volume from 3.375 L to 1 L 
for the enrichment of artificially inoculated ground beef samples, Guerini et al., (2006) observed 
similar recovery rates of E. coli O157:H7, indicating a much lower volume is sufficient for 
enrichment purposes. 
Other methods aimed at limiting the required volume(s) even more so involve using 
microtiter plates (a working volume of 100 to 300 µL per well is common) to miniaturize 
growth-based assays for screening a large number of samples per analysis in µL rather than L-
based volumes (Hüser, 2006). While STEC isolates have not been examined directly, there is 
precedent for comparison of miniaturized growth conditions with standard incubation methods. 
Much of this work was done as a means to assess particular E. coli isolates as potential whole 
cell biosensors. Critical to this assessment was the impact on growth kinetics since growth 
response was the measurement being used. Accordingly, a series of studies were conducted with 
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nonpathogenic E. coli amino acid mutants to assess their growth responses to different quantities 
of the required amino acid and potential to serve as a bioavailability assay for that particular 
amino acid (Froelich Jr. et al., 2002b, 2005; Zabala-Díaz et al., 2004; Froelich Jr. and Ricke, 
2005; Chalova et al., 2009, 2010). Froelich Jr. et al., (2002a, b) used growth kinetic estimates of 
these mutants after growth in minimal media based on Lineweaver-Burk plots of growth rate to 
assess response to incremental changes in amino acid concentration. By plotting the reciprocal 
exponential growth rate versus the initial concentration of methionine, the Lineweaver-Burk plot 
was used to calculate the affinity constant (substrate concentration at which the growth rate is at 
half-maximum) and maximum potential growth rate of microorganisms grown in media 
containing incremental increases of the essential amino acid (Froelich Jr. et al., 2002a, b). 
In a follow up study, Zabala-Díaz et al., (2002) directly compared a classical tube assay 
with a microtiter plate format to determine the affinity and growth rate of an E. coli methionine 
auxotroph grown on the same incremental methionine concentrations (3.3 µM increments, 0 to 
26.8 µM). While the affinity estimates between the two methods were similar, these authors 
observed the maximum growth rates to be significantly higher (P < 0.05) when grown in culture 
tubes versus microtiter plates. These differences suggest that bacterial growth responses are 
methodology dependent, and although microtiter plates are beneficial for reducing media, 
reagents, and labor, the differences in growth rates should be considered when employing growth 
based detection enrichment methods and most probable number types of isolation or estimation 
for enumeration when changing from culture tubes to microtiter plate assays (Zabala-Díaz et al., 
2002). 
More recently, Berghaus et al., (2013) miniaturized the most probable number assay to 
estimate the bacterial populations of Campylobacter and Salmonella spp. in farm and processing 
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plant samples from broiler chicken flocks. To estimate Salmonella populations, enrichment 
procedures as recommended by the USDA for Salmonella enrichment procedures were adapted 
for 2-mL deep-well microtiter plates (FSIS, 2014). Once samples were diluted across a microtiter 
plate containing tetrathionate media (0.8 mL), plates were incubated overnight, and 0.1 mL of 
culture from each microtiter plate well was transferred to corresponding microtiter plate wells 
containing Rappaport Vassiliadis media  (0.9 mL). Following the secondary enrichment 
procedure, 1 μL of culture from each microtiter plate well was transferred onto xylose lysine 
Tergitol 4 agar via a pin tool replicator, which negates the labor intensive practice of individually 
transferring large quantity liquid cultures to subsequent agar plates for enumeration (Berghaus et 
al., 2013). Similar methods that require evaluation of a large number of samples and implement 
smaller volumes of media, as well as limit the labor associated with conventional laboratory 
methods will likely be necessary to simplify, and reduce the time required to screen greater 
numbers of samples for microorganisms (Berghaus et al., 2013). 
It has been suggested that an enrichment step may be unavoidable due to the requirement 
to detect single cells of STEC, and that it would be research time well spent to improve media 
for better growth of STEC (Wang et al., 2013). Among other aspects, additional studies remain 
to be conducted to determine growth variations between the relevant STEC serotypes. This is 
critical, as general assumptions cannot necessarily be made for other STEC serotypes based on 
results obtained from studies on only a few serotypes. When several strains of Salmonella 
serovars were grown in an enrichment culture, Gorski (2012) observed higher recovery rates of 
Salmonella serovars in serogroups C2 and E when compared to Salmonella serovars in 
serogroups B or C1. These recovery rate differences suggest that multiple enrichment protocols 
may be necessary to account for all of the microorganisms actually present in a sample (Gorski, 
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2012). In addition to adopting several enrichment protocols to reduce and potentially eliminate 
bias recovery of microorganisms, determining the media in which they grow most rapidly should 
reduce enrichment time and accelerate the overall food detection analytical process. The 
following subsection examines current media developed for use with STEC. 
 
Current STEC culture growth procedures 
The USDA-FSIS currently recommends the use of Modified Tryptone Soy Broth (mTSB) 
for enrichment of raw meat product samples (FSIS, 2013b). This medium is utilized for E. coli 
O157:H7, the “big six” STEC as well as Salmonella enrichment (FSIS, 2013c). The main 
component of the mTSB medium is pancreatic digest of casein (Holt and Krieg, 1994), which 
provides the carbon and nitrogen compounds essential for energy production, protein and nucleic 
acid synthesis, and growth (Roberts et al., 1955). Following an enrichment step in mTSB, 
samples are screened for the presence of virulence genes stx and eae with a polymerase chain 
reaction (PCR) assay, and positive samples are further tested for the “big six” with an additional 
PCR analysis (FSIS, 2011, 2013c). Following the “big six” PCR assay, immunomagnetic beads 
(specific for the serogroup(s)) are added to the respective potentially positive samples to recover 
the cells, and the immunomagnetic bead-cell complexes are plated on modified Rainbow Agar 
(mRBA) for culture confirmation and further analysis. Modified Rainbow Agar contains 0.15 
mg/L of potassium tellurite, 5 mg/L of sodium novobiocin, and 0.05 mg/L of cefixime trihydrate 
(FSIS, 2013c). The antibiotics novobiocin and cefixime are added to the media to inhibit the 
growth of Proteus spp. and other microorganisms that are capable of reducing the tellurite, the 
selective compound in mRBA (Zadik et al., 1993). Traditionally, STEC serogroups have been 
considered difficult to distinguish on chromogenic agar, and although recent work suggests that 
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phenotypic distinctions may be possible, it is still recommended that independent confirmation 
assays should be used to complement the initial identification with chromogenic agar 
(Kalchayanand et al., 2013). 
Distinguishing E. coli O157:H7 from other E. coli strains with routine enteric media is 
difficult due to the fact that it requires testing for sorbitol fermentation (March and Ratnam, 
1986). E. coli O157:H7 typically cannot ferment sorbitol (at least not in the first 24 hours) 
(Farmer III and Davis, 1985), and is distinguishable (appears as a colorless colony) from generic 
and non-O157 E. coli (Atkinson et al., 2012) when cultured on sorbitol-MacConkey agar 
(SMAC) (March and Ratnam, 1986), which is the primary medium used to culture E. coli 
O157:H7 (CDC, 2007b). However, there have been instances of E. coli O157:H7 fermenting 
sorbitol (Karch et al., 1993; Werber et al., 2011; Sallam et al., 2013), and an outbreak in 1999 
due to sorbitol-fermenting E. coli O157:H7 exemplifies the limitations of SMAC (Ammon et al., 
1999) and the need for more appropriate media. 
Recent advances in microbiological methods may have overshadowed certain aspects of 
bacterial growth physiology during enrichment and there is a need for this to be reconsidered 
now that multiple serotypes are known to be involved (Chen et al., 1993; Brehm-Stecher et al., 
2009). The argument that it is necessary to enrich samples for a substantial amount of time (16 
hours or more) will likely always be raised, but research efforts on media improvements and 
increasing the ability to recover microorganisms following shorter enrichment periods will more 
precisely define the time needed for enrichment and the subsequent overall detection process. In 
order to achieve the fundamental objective of rapid detection (less than 12 hours), alternative 
approaches need to be explored to reduce the enrichment duration (Chen et al., 1993). Following 
the enrichment step, positive samples must be cultured and serotyped for epidemiology purposes 
  
26
(Vallières et al., 2013). If reducing the background microflora is necessary due to the lack of 
suitable media for colony differentiation, then alternative approaches become obligatory. If there 
were an enrichment medium that could be consistently converted from a nonselective to a 
selective state after a given enrichment time, the issue of growing foodborne pathogens in a 
shorter amount of time, as well as being able to eventually reduce the background microflora for 
culturing purposes would be attainable. Compounds that inhibit non-relevant microbial 
populations could be either encapsulated or administered in some sort of initially inactive state or 
form to prevent initial inhibition, but allow eventual release into the medium at the proper time 
and inhibitory concentration(s). Additionally, devising a medium containing compounds that are 
not known to inhibit molecular detection assays may be appropriate.  
With this in mind, there is also the likelihood that the growth response of STEC may vary 
in different food systems (Palumbo et al., 1997), thus several enrichment protocols may be 
needed to successfully enrich STEC serogroups that do not grow within the same response times 
in a single medium. If it is expected to produce rapid results, an enrichment period of 12 to 16 
hours is unacceptable. Although the growth of unwanted background microbiota may 
outcompete the target microorganism(s) (Suo and Wang, 2013), a richer, less selective medium 
in some cases may still be applicable if the STEC in question can grow faster than the 
background microbiota. A longer duration of enrichment is not necessarily better, especially with 
techniques that enable pathogen detection by non-culture methodologies, such as molecular and 
immuno-based systems. 
 
Bacteriophage and Immuno Assays 
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Bacteriophages have been implemented to reduce bacterial loads at the pre- and 
postharvest food processing stages and have been investigated for foodborne pathogen detection 
purposes (Ricke et al., 2012; Schmelcher and Loessner, 2014). Bacteriophages require bacteria 
as a host for replication and survival, and the understanding of the bacteriophage-bacteria 
relationship has provided alternatives to molecular methods and use of antibodies for detection. 
Bacteriophages have been used for magnetic separation of cells (phagomagnetic separation) 
(Liébana et al., 2013), use in an ELISA (Galikowska et al., 2011; Willford et al., 2011), and 
other detection purposes by direct fluorescent labeling (Goodridge et al., 1999; Willford et al., 
2011). Compared to antibodies, bacteriophages are more stable, less expensive, easier to produce 
and isolate, have longer shelf lives, and do not require animals for production (Balasubramanian 
et al., 2007; Galikowska et al., 2011). Bacteriophages can be implemented in many detection 
assays, and a wide range of potential applications have been reviewed (Arugula and Simonian, 
2014; Schmelcher and Loessner, 2014; Singh et al., 2013). 
 
PCR Detection Assays 
Molecular approaches involving the isolation, detection, and in some cases quantitation 
of either DNA or RNA were instrumental in the emergence of rapid detection systems for STEC. 
Consequently, extensive development and improvement on these techniques became possible for 
application to STEC. Once developed and optimized, commercialization and widespread 
adaptation by the food industry became commonplace. Much of this has been extensively 
reviewed elsewhere either as general concepts for all pathogens, or for specific organisms such 
as STEC and other pathogens (Higuchi et al., 1993; Malorny et al., 2003; Maciorowski et al., 
2005; Girones et al., 2010; Elizaquível et al., 2014; Park et al., 2014). Therefore, in the current 
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review, only the highlights will be discussed for molecular detection of STEC since much of this 
has been covered in considerable detail elsewhere (DebRoy et al., 2011b; Gerritzen et al., 2011; 
Fratamico and Bagi 2012; Paddock et al., 2012; Svoboda et al., 2013). 
Polymerase chain reaction-based methods can be used to identify the presence of 
microorganisms by targeting specific portions of the DNA or RNA that are characteristic of the 
target organism. These genomic sequences are typically amplified with sequence-specific 
primers and DNA polymerase. In addition to amplifying DNA or RNA, PCR can be applied to 
differentiate mutations and quantitate levels of gene expression (Park et al., 2014). Nucleic acids 
(nucleotides) are the structural components of DNA and RNA, and each organism possesses a 
unique sequence of these nucleotides. Many organisms contain similar DNA and RNA 
sequences, but there are also generally sequences among a genus, species, or serovar that are 
unique to that particular population, and can be targeted for identification. This is the principle 
upon which PCR is applied for detection and identification. Primers used for amplification are 
oligonucleotide sequences that are essentially identical to the nucleotide segment of an organism 
or group of organisms, and in theory, if the organism that the primers target is present, the 
nucleotide sequence(s) will be identifiable. A key component to the process of any PCR assay is 
to successfully isolate DNA from samples (Yeni et al., 2014), which can subsequently be 
detected with nucleotide specific primers. Primers have been developed to detect virulence genes 
such as stx1, stx2 and eae (Bae et al., 2010; Bosilevac and Koohmaraie, 2012; Dargatz et al., 
2013; Guy et al., 2014), and distinguish E. coli pathotypes (Nataro and Kaper, 1998), as well as 
common STEC serotypes (Paton and Paton, 1998; DebRoy et al., 2011b; Fratamico and Bagi, 
2012; Paddock et al., 2012). In theory, with proper DNA extraction techniques and sufficient 
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DNA purity level, PCR methods can detect a single DNA molecule, which can be amplified to 
obtain a greater amount of DNA for further analysis (Hedman and Rådström, 2013). 
Conventional single and multiplex PCR are used to amplify a specific DNA region to 
generate sufficient copies to be detectable such that the presence of the target organism(s) can be 
visibly determined by agarose gel electrophoresis. In a multiplex PCR assay, multiple primers, 
each specific for a certain serotype and/or virulence gene(s), can be included in a single PCR 
assay to detect several factors in a single reaction, but optimizing multiplex PCR conditions can 
be difficult (Maciorowski et al., 2005). Conventional single and multiplex PCR requires agarose 
gel electrophoresis for analysis, and certain parameters cannot be determined. Real-time PCR is 
advantageous in that it does not require gel electrophoresis for analysis – results as the name 
suggests can be analyzed in real-time (Yeni et al., 2014). Real-time quantitative PCR (qPCR) is a 
highly accurate and sensitive type of PCR that can be performed to quantitatively determine the 
phylogeny and function of genes in sample matrices (Smith and Osborn, 2009; Girones et al., 
2010; Lin et al., 2011; Guy et al., 2014). 
Real-time PCR is currently a key part of the screening process for pathogens in the food 
industry. One commercial method known as the BAX® System real-time PCR Assay is approved 
by the USDA-FSIS for STEC detection in the food industry (DuPoint, 2014). The BAX systems 
simplify a PCR assay by combining the necessary reagents into a single tablet (which is pre-
packed into PCR tubes) to reduce the possibility of contamination and error during PCR 
preparation (Bailey, 1998; Shearer et al., 2001; Frausto et al., 2013). 
 
Conclusions and Future Directions 
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As certain STEC serotypes emerged and were declared adulterants, there was an increase 
in detection methods. Determining the most appropriate assay will become difficult if additional 
serotypes are declared adulterants. It will be difficult to predict the most appropriate approaches 
in the future, and as more information on the characteristics of these serotypes is revealed, an 
increase in automated assays will likely be required. Additionally, procedures that concentrate 
large sample sizes (such as immunomagnetic separation) will more accurately determine the true 
bacterial population(s) in food matrices (Baker et al., 2015). 
Although STEC serotypes may not proliferate uniformly in certain environments, 
implementing several enrichment protocols per sample would be a more time consuming and 
inconvenient exercise that will not likely be practiced by industry. However, if continued 
research proves the importance of several enrichment protocols, these practices may become 
commonplace for sample analyses. Revealing the physiological adaptation mechanisms of STEC 
has been shown to be a continuous and daunting task. As microorganisms continually change, 
researchers must optimize methods in accordance with regulations and ensure that they are 
adaptable to future regulations. 
 Whole genome sequencing of STEC has been performed as a means to investigate the 
different characteristics of STEC variants, and as whole genome sequencing continues to become 
more feasible, a large database will likely be available to determine why certain STEC serotypes 
are more prevalent in food products and associated with illness (Franz et al., 2014; Lindsey et al., 
2014). 
While molecular approaches have dramatically improved detection times and sensitivity, 
several issues remain. For example, attaining whole cells from samples would likely be useful 
for illness and outbreak investigations due to the fact that a pure culture is needed for serotyping 
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as well as for potential further characterization (Vallières et al., 2013). During outbreak 
investigations, stool samples acquired from ill persons could be lyophilized as whole cells 
following capture and separation with immunomagnetic beads, which would provide a stock of 
samples that could later be cultured and characterized to link illnesses. In the sense of having 
samples that could later be of use for serotyping, the use of immuno-based methods would be 
advantageous over cell destruction based methods such as molecular assays based on the 
extraction of DNA or RNA. For molecular techniques, DNA is generally extracted from cells for 
PCR analysis, and DNA samples are lyophilized and stored. These samples would be useful for 
additional analyses such as whole genome sequencing. 
Stocks consisting exclusively of DNA may be suitable for whole genome sequencing, but 
preserving culture collections for future research may also be necessary, especially conventional 
systems that implement serotyping. The ability to metabolically characterize isolates could help 
better understand ecological niches, which may reveal why certain isolates suddenly become 
prevalent in certain environments. Maintaining culture collections provides the opportunity for 
subtyping in future laboratory procedures, which may help further characterize pathogens with 
various techniques. Additionally, as new detection and characterization platforms (advancements 
in whole genome sequencing technology) surface, being able to compare conventional assays 
with new technology may provide useful data to better understand and optimize the newly 
developed techniques. As always, confidently developing feasible and timely protocols will be 
beneficial to the food industry and public health. 
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Table 1. Illness and Cost Estimates of E. coli and other common pathogens in the U. S. 
annually 
Pathogen Illnesses^ Cost (millions)* 
Norovirus 5,461,731 3,677 
Salmonella  (nontyphoidal) 1,027,561 11,391 
Staphylococcus aureus 241,148 168 
STEC non-O157 112,752 154 
STEC O157 63,153 635 
 Non shiga-toxin producing E. coli 29,876 40 
 ^ Scallan et al., 2011     
 * Scharff, 2011, cost estimate model accounts for pain, suffering and disability 
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Table 2. Timeline of outbreaks, recalls, and government response with relation to STEC  
Year Summary Reference 
1977 Cytotoxicity of E. coli is first observed Konowalchuk and Speirs, 
1977 
1982 Food-borne outbreaks led to the identification of E. coli O157:H7 Riley et al., 1983 
1993 Washington state outbreak (including Idaho, Nevada, and California) Bell et al., 1994 
1994 FSIS declares E. coli O157 to be an adulterant in raw non-intact beef Schuller, 1998 
1996 E. coli O157:H7 outbreak in Sakai City, Japan - over 7,000 children linked to radish sprouts 
in school lunches 
Sobel et al., 2002 
1997 Colorado recall of 25.6 million pounds. of frozen ground beef patties due to E. coli O157:H7 CDC, 2007a 
2002 Colorado recall of 18.6 million pounds of ground beef products due to E. coli O157:H7 Vogt and Dippold, 2005 
2006 U. S. outbreak of E. coli O157:H7 linked to spinach Grant et al., 2008 
2011 FSIS declares E. coli O26, O45, O103, O111, O121 & O145 to be adulterants in raw non-
intact beef 
FSIS, 2011 
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Table 3. Enrichment media and growth considerations 
Factor Example Reference 
Temperature 37 or 42°C  Guerini et al., 2006 
Sample Type of carcass or product  Brehm-Stecher, Young et al., 2009 
Nutrient 
concentrations 
Optimal for target microorganisms?  Greasham and Herber, 1997 
pH 6.5-7.5 optimal for bacteria  Greasham and Herber, 1997; Grant, 2004 
Water Type used for making media  Greasham and Herber, 1997 
Sterilization No contamination  Greasham and Herber, 1997 
Labor Difficulty/how time consuming?  Guerini et al., 2006 
Cost  Guerini et al., 2006 
Volume How much is efficient for growth? 
Static or Shaking 
Serotype Variations among serotypes?   
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Introduction 
Although commensal E. coli are beneficial to fundamental biological research and are a 
part of the intestinal indigenous microflora population, certain serotypes of E. coli exist that are 
considered pathogenic and represent a high level risk to public health and the food industry. Any 
microorganism that can cause disease is defined as a pathogen. More than 400 serotypes of E. 
coli have been isolated, 100 of which have been associated with human illness thus far (Brenner 
et al., 2005). Pathogenic E. coli are divided into six pathotypes: enterotoxigenic, 
enteropathogenic, enterohemorrhagic, enteroaggregative, enteroinvasive, and diffuse-adhering E. 
coli (ETEC, EPEC, EHEC, EAEC, EIEC, DAEC, respectively) (Alteri and Mobley, 2012), and 
although there are similarities, each pathotype possesses unique pathogenic mechanisms (Nataro 
and Kaper, 1998). Enterohemorrhagic E. coli are especially problematic to human health, and 
these isolates exhibit unique virulence mechanisms. In 1977, cytotoxic effects from E. coli were 
first observed in a Vero cell (an African Green Monkey kidney cell line), and were described as 
verotoxogenic E. coli (VTEC) (Konowalchuk et al., 1977; Karmali et al., 1985). The VTEC 
strains are included in the EHEC pathotype and are better known as Shiga toxin (Stx)-producing 
E. coli (STEC). 
The detection of STEC and Stx toxins in foods is important at the manufacturing, 
processing, and consumer settings. Immuno-based detection methods have been implemented for 
such purposes, and these non-molecular detection assays invoke a direct interaction(s) with intact 
STEC cells. This review has a particular emphasis on immunological approaches, and highlights 
potential future directions for developing detection systems and strategies for use in industrial 
settings. The objective of this review is to provide information on the immunological methods 
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that have emerged to as a means to detect and quantify pathogenic E.coli as well as concentrate 
and collect bacteria from food matrices.  
 
Immuno-based detection assays 
The immune response and the development of the immunoassay 
Escherichia coli, like most bacteria and other organisms, possess structures on the outer 
surfaces that are well-defined antigens due to their ability to consistently trigger an immune 
response in the host. This response is characterized by specific host production of antibodies, 
which directly interact with these antigens in a consistent manner that lends to the ability to use 
this antigen-antibody matrix as a diagnostic tool.  
Escherichia coli have many well defined antigens – the O antigen defines the serogroup, 
and the specific combination of O and H antigens classify the serotype (Edwards and Ewing, 
1986; Stenutz et al., 2006; DebRoy et al., 2011). They possess an endotoxin known as the 
lipopolysaccharide (LPS) embedded in the outer membrane, which consists of three parts; the 
lipid A region, core region, and the O polysaccharide. The lipid A region, which is anchored in 
the hydrophobic portion of the Gram-negative bacterial outer membrane, contributes to the 
toxicity of the LPS, and is well conserved among Gram-negative bacteria (Stenutz et al., 2006; 
DebRoy et al., 2011). The core region, which consists of oligosaccharides, connects the lipid A 
region to the O polysaccharide, which is commonly referred to as the O antigen. Escherichia coli 
may also possess a flagellum or flagella, which is an outer membrane structure identified in 
serological reactions by the H antigen. While H antigen characterization is typically only 
necessary for outbreak investigation purposes, O antigen identification is the primary means of 
serotyping (Atkinson et al., 2012). 
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Antibody sources 
General concepts 
To understand the how antibodies interact with bacterial antigens, it is important to 
understand the function and sources of antibodies. Antibodies are a family of proteins of the 
adaptive immune system that defend the host by binding to antigens. Antibodies are produced by 
numerous unique B cells that have been stimulated by the antigen binding to the B cell’s antigen-
receptor to differentiate into antibody-producing cells (plasma cells) in the lymphoid organs 
(spleen, lymph nodes, among others). For instance, there are hundreds of millions of B cells in 
the human body, and each have a pre-determined specificity for a unique antigen that the 
immune system might potentially encounter (Greener, 2005). The antibody that is produced by 
the antigen-specific B cells is a soluble form of the B cell’s antigen receptor. 
All antibodies have a similar structure in common that determines the functionality of the 
antibody, and this portion of the antibody is known as the constant region. The variable regions, 
which contain the complementary determining sites for antibodies, are responsible for binding 
the respective antigens, and each antibody consists of two identical heavy chains and two light 
chains, thus providing at least two sites capable of binding an antigen (Abbas et al., 2012). 
Following exposure of an antigen to its specific B cell, clonal expansion occurs – B cells 
proliferate and differentiate into either effector cells (plasma cells) to combat the current antigen, 
or memory cells to address future antigen exposure. Affinity maturation occurs during this 
process - the genetic code for the variable region of the B cell rearranges, and antibodies that are 
unique for the antigen that originally contacted the B cell are subsequently produced (Abbas et 
al., 2012). The complementary determining regions of an antibody interact with an antigen at the 
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site known as an epitope, or determinant, which usually consist of 6 to 8 amino acids (Nelson et 
al., 2000). The strength at which a single antibody binds to an epitope is defined as the affinity, 
and the overall strength of the antibody-antigen interaction is defined as the avidity (Abbas et al., 
2012). 
 
Polyclonal antibodies 
During an immune response, numerous clones of B cells with specificity for an epitope of 
a complex antigen will become activated. While each clone of B cells produces antibody with 
each cells’ unique specificity, collectively the plasma cells originating from different B cell 
clones produce a heterogeneous mixture of antibodies, which are capable of binding several 
different antigen epitopes, and are known as polyclonal antibodies (Stills, 2012). Antibodies are 
typically generated by administering an antigen into an animal to produce an immune response, 
and rabbits are the most common animal model for polyclonal antibody production (Stills, 2012). 
The immunization process leads to the production of polyclonal antibodies, which respond to 
each of the specific different epitopes of a particular antigen. 
Many antigens are too small to trigger an immune response alone, and require a carrier 
protein to which the antigen (hapten) is bound making the small antigen immunogenic. A hapten 
is composed of small functional groups (such as glucose) (Berzofsky and Berkower, 1999a) and 
any alteration in these small structures can potentially change the function of an epitope. To limit 
conformational changes of epitopes throughout the immunization process, microorganisms are 
typically purified or fixed with formaldehyde before being injected into a host. Formaldehyde 
reacts with the amino acids (primarily lysine) to form cross-links between proteins, and stabilize 
the epitope structure (Hopwood, 2002). Purification and fixation procedures ensure the antigen 
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retains its structural conformation throughout the immunization process, which increases the 
likelihood that B cells will only produce antibodies specific for the immunogen. If cells are not 
fixed prior to immunization, the protein or sugar structure of the antigen can change 
conformation while inside the host, and B cells that recognize these altered antigen structures 
will produce unwanted antibodies. Additionally, fixation ensures the following injections into a 
host help B cells eventually secrete more specific antibodies due to repeated exposure to an 
identical antigen, and fixed antigens can result in greater immunogenicity when compared to 
unfixed antigens, which are more susceptible to degradation (Van Epps, 2006).  
 The time at which the B cells are extracted from a host is critical – if not gathered during 
an active immune response to the administered antigen, there will likely be too many memory B 
cells of different specificities to sort through since there are millions of B cells (each with unique 
specificity) in a host at any given time (Zeliadt, 2014). Following the initial immunization, 
several booster injections can be administered, which is necessary to continue exposure of 
antigens to B cells. Once the antigen in a host is neutralized, a small number of activated B cells 
will differentiate into memory cells, and most will die by apoptosis (Schijns et al., 2008). 
Additionally, booster injections typically result in a higher concentration of antigen-specific 
antibodies. For example, Potter et al., (2004) observed a 45 fold increase in specific antibody 
titer following a booster vaccination 21 days after the initial immunization of E. coli O157:H7 
type III secreted proteins in eight calves (Potter et al., 2004). 
Polyclonal antibodies are often acquired from a host via blood sampling, which involves 
collection from the host every two weeks (Shimizu et al., 1988), and upon acquiring the blood, 
isolating antibodies is a relatively simple procedure. Blood can be stored at 4 °C to initiate 
clotting, and centrifugation will separate the clots from the serum that consists of the polyclonal 
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antibodies (Layton et al., 2011). Once the blood clots are removed, sodium azide can be used to 
preserve the sample, which can be stored at 4 °C until the antibodies are analyzed. 
Chicken laying hen eggs have been utilized as an alternative method to recover 
polyclonal antibodies. Polyclonal antibodies are present in the yolk of hen eggs (commonly 
referred to as egg yolk antibodies (IgY)), and are a source of passive immunity to newly hatched 
chicks, which have an immune system that is initially incapable of fighting infection (Malkinson, 
1965). By immunizing a hen with an antigen, high concentrations of egg yolk antibodies (IgY) 
(typically higher than in mammalian hosts) can be recovered from hen eggs on a daily basis 
during an elevated immune response that produces the antigen-specific polyclonal antibodies 
(Ricke et al., 1988; Ricke and Schaefer, 1990; Biswas et al., 2010; Herrera et al., 2013). 
Additionally, unlike mammalian antibodies, IgY does not inadvertently activate the mammalian 
complement system, which results in an undesired immune response (Akita and Nakai, 1993). 
Limited work has been done with egg yolk antibodies produced against STEC, and most 
of this has focused on their use as a therapeutic agent in animals susceptible to STEC. Sunwoo et 
al., (2002) isolated egg yolk antibodies from chickens that were immunized with E. coli 
O157:H7 whole cells. E. coli O157:H7-specific egg yolk antibodies were sufficient in inhibiting 
E. coli O157:H7 growth at concentrations higher than 1.17 mg/mL, and following visual 
analyses of immunoelectron micrographs, these authors suggested the specific egg yolk 
antibodies were capable of binding to the bacterial surface of E. coli O157:H7, which altered the 
bacterial surface structure(s) and inhibited growth (Sunwoo et al., 2002; Schade et al., 2005).  
In efforts to produce E. coli specific IgY antibodies as a food ingredient, Shimizu et al., 
(1988) injected formalin-fixed E. coli and an adjuvant into White Leghorn hens to elicit the 
production of anti-E. coli Immunoglobulin Y (IgY). An enzyme-linked immunosorbant assay 
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(ELISA) was used to determine IgY yield by adding the anti-E. coli IgY to microtiter wells 
containing predetermined concentrations of heat-killed E. coli lipopolysaccharide (Shimizu et al., 
1988). Similarly, Akita and Nakai, (1993) compared four methods to purify anti-E. coli IgY from 
egg yolk, which typically contains a substantial amount of lipids. These authors experienced a 
higher yield, purity, and ease of use with a method known as the water dilution method when 
compared to three alternative methods involving polyethelene glycol, dextran sulphate, and 
xanthan gum (Akita and Nakai, 1993). 
Bacterial and viral diseases in calves and piglets have been treated with IgY antibodies to 
neutralize and/or eradicate the bacterial or viral antigen(s) (Schade et al., 2005). Yokoyama et 
al., (1992) reduced diarrheal disease in neonatal piglets by orally administering spray-dried egg 
yolk antibodies (specific for ETEC). Following ELISA trials that revealed egg yolk specificity 
for each ETEC strain, a scanning electron microscope was used in vitro to observe the adhesion 
ability of these ETEC strains in the small intestine of piglets, with and without orally 
administered egg yolk antibodies. These authors observed successful adhesion of ETEC strains 
to the duodenal and ileal epithelial cells of untreated piglets, and due to the reduced adhesion of 
ETEC strains in treated piglets, suggested egg yolk antibodies exhibited specific anti-fimbrial 
mechanisms (Yokoyama et al., 1992). 
Egg yolk antibodies involve relatively simple procedures, as well as the opportunity to 
frequently isolate high concentrations of antibodies (it has been suggested approximately 17 to 
35 g of total IgY can be acquired from a single hen annually) (Schade et al., 2005). Also, hen 
eggs provide a feasible source of antibodies compared to procedures involving other animals (the 
cost to maintain hens is generally less when compared to rabbits) (Schade et al., 2005). 
 
  
64
Monoclonal antibodies 
While polyclonal antibodies are specific for multiple epitopes of an antigen, monoclonal 
antibodies have a unique specificity and have revolutionized antibody-based therapeutics, but 
production requires a more labor intensive and time-consuming in vitro process for development. 
The basis and methods of monoclonal antibody production have been extensively described 
elsewhere (Strockbine et al., 1985; Nelson et al., 2000; Skinner et al., 2013), and will only be 
briefly discussed here. 
Once B cells are activated, they typically have a short life span following the 
neutralization of an antigen in a host. The fact that an activated B cell (plasma cell) secretes 
antibodies of a single specificity provides an opportunity to join a plasma cell with an immortal 
tissue cell culture, and create unique cells that become a large source of antigen-specific 
antibodies due to their continued proliferation. Köhler and Milstein, (1975) first described efforts 
to produce monoclonal antibodies by fusing plasma cells to myeloma tissue culture cells to 
produce antibody-producing permanent tissue culture cell lines (Köhler and Milstein, 1975).   
The primary method of monoclonal antibody production is via hybridoma technology, 
which involves the production of an immortal plasma cell in vitro (Nelson et al., 2000; Byrne et 
al., 2009). Plasma cells from the bone marrow, primary lymph nodes, and spleen of an 
immunized host can be recovered and fused with immortal myeloma cells, but murine-derived 
splenocytes are used for the vast majority of hybridoma fusions. Hybridoma technology is used 
to develop immortalized plasma cells (hybridoma cells), each of which produce identical 
monoclonal antibodies of unique specificity for an epitope of an antigen (Köhler and Milstein, 
1975; Leenaars et al., 1999; Byrne et al., 2009).  
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Polyethylene glycol is generally used as the hybridoma cell fusing agent, and causes 
extensive cross-linking between a myeloma and B cell (Clark, 1991). A common problem with 
hybridoma cell culture production is the presence of unfused myeloma cells that can ultimately 
outgrow successfully fused hybridoma cells. The fusion process as well as myeloma-cell 
elimination procedures that follow are based on nucleotide biosynthesis concepts that are 
characteristic of all cells. Nucleotide synthesis is essential for survival of cells, and cells produce 
nucleotides by either the de novo or the salvage pathway. Only cells that contain an enzyme 
known as hypoxanthine guanine phosphoribosyltransferase (HGPRT) can utilize the salvage 
pathway. To eventually eliminate unfused myeloma cells, HGPRT-deficient myeloma cells are 
used in the fusion process, and are limited to the de novo nucleotide biosynthesis pathway. 
Following the fusion process, cell cultures are incubated in HAT selective medium, 
which ultimately eliminates any unfused myeloma cells (Nelson et al., 2000). The HAT selective 
medium contains hypoxanthine, aminopterin, and thymidine, and aminopterin blocks the de novo 
pathway, which is required for HGPRT negative cells, thus eliminating any myeloma cells that 
did not fuse with a B cell. Since hybridoma cells consist of B cells, these cells can utilize the 
salvage pathway for nucleotide synthesis and survive. 
Once cells are grown in the HAT selective medium, each microtiter well containing 
antibodies that react with an administered purified antigen can be transferred to a separate 
microtiter plate. Cells are diluted throughout the microtiter plate with the intention to isolate one 
hybridoma cell per microtiter well, thus acquiring a source of antibodies with a unique 
specificity (Clark, 1991). This ensures that a particular population of antibodies are the source of 
a single hybridoma cell (Clark, 1991; Nelson et al., 2000; Huang et al., 2013; Zeliadt, 2014). 
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Current monoclonal antibody production methods are time consuming and complicated, 
and require screening procedures to obtain a culture containing a single hybridoma cell. 
Alternative monoclonal antibody production methods are surfacing due to the fact that animal-
derived antibodies can trigger an undesired immune response in humans. In a somewhat similar 
fashion to hybridoma technology, human memory B cells can be isolated from a purified blood 
sample and infected with Epstein-Barr virus to obtain immortal cell cultures that secrete an 
antibody of a desired specificity (Zeliadt, 2014). 
Monoclonal antibodies are important in Western blots, which are commonly used for 
protein analyses. Once proteins are separated by gel electrophoresis, labeled monoclonal 
antibodies can be applied to detect various proteins, revealing the different types of proteins 
(antigens) from a sample. A primary motivation for monoclonal antibody production is due to 
the potential for therapeutic applications in humans and animals (Nelson et al., 2000; Greener, 
2005; DeKosky et al., 2013). Monoclonal antibodies are a useful diagnostic tool, and can be used 
to measure hormone levels, as well as the presence of toxins in biological fluids (Berzofsky et 
al., 1999b). In addition to many other applications, monoclonal antibodies can be used to detect 
proteins and toxins in food systems. 
He et al., (2013) recently developed five Stx2-specific monoclonal antibodies to detect 
the Stx2 toxin in milk with immuno-based detection assays.  Following the production of the five 
Stx2-specific monoclonal antibodies, Western blots were used to determine toxin binding and 
specificity. These authors observed no cross reactivity with the Stx1 toxin, and each distinct 
monoclonal antibody displayed different levels of affinity for A and/or B subunits of the Stx2 
toxin. Two of the produced monoclonal antibodies were specific for Stx2 subunits A and B and 
both exhibited lower disassociation constants than that of the three antibodies specific for only 
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subunit A (He et al., 2013). Each of the monoclonal antibodies (except Stx2-2) bound to all four 
of the Stx2 variants tested in the Stx2 variant binding experiments (He et al., 2013). 
The type of antibody most appropriate for immunoassays is dependent on several factors 
such as the format of an assay in which the antibodies will be used, as well as the other 
advantages and limitations often times associated with monoclonal and/or polyclonal antibodies 
(Table 1). Although either monoclonal or polyclonal antibodies are most appropriate in certain 
circumstances, some immunoassays involve both types. The general concepts of these 
immunoassays will be discussed in the following sections. 
 
Immunoassay 
General concepts 
Once the realization that antibodies could be used to discern certain antigens, it became 
intuitively apparent that antibody-antigen reactions could be used to classify, detect, and 
ultimately quantify microorganisms. Not surprisingly, numerous strategies were conceived and 
developed to detect this reaction as a function of an immunoassay. Numerous immunoassays 
have emerged over the years for targeting pathogens in clinical stool samples or industrial food 
products. In the food industry, immunoassays have been applied to detect and quantify numerous 
food components (proteins, enzymes, vitamins, among others) and contaminants 
(microorganisms, toxins, pesticides, hormones, among others) (Fukal and Káš, 1989). 
Immunoassays can be designed for detection due to the understanding of the 
immunochemical antigen-antibody complex that is formed during an immunological reaction 
between the analyte (antigen) and the reagent (antibody) (Káš et al., 1986). An immunoassay can 
be used to assess the presence and/or concentration of an antigen. Early work focused on 
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visualization of the agglutination and subsequent visible clumping of extensive numbers of cells 
and antibodies that formed large lattice type structures, which could be viewed on a microscope 
and scored accordingly (Burnet, 1934; Pauling, 1940). 
Further refinement occurred with the development of radial immunodiffusion assays that 
were first described in 1949 (Ouchterlony, 1949), and are commonly referred to as the double 
disk diffusion assay or Ouchterlony assays. Radial immunodiffusion assays were based on the 
principle that similarly-structured molecules will diffuse at similar rates through an agarose gel 
that allows free movement of the molecules (Lam and Mutharia, 1994). The double disk 
diffusion assay can be used to determine the lowest concentration of antigen needed for 
precipitation of an antibody-antigen complex; the lowest antigen concentration to form a 
precipitin line can be used in additional assays to conserve antigen stock(s). 
In a follow-up to the early development research, Ouchterlony, (1968) published a 
methodology oriented handbook which describes the conventional, as well as alternative formats, 
techniques, and modifications that were available at that time to perform a double disk diffusion 
assay. As described at the time, the center portion of the agarose gel typically consisted of an 
antibody in a well (disk), and surrounding wells containing various antigens could be positioned 
of equal distance around the center antibody. Following diffusion of the antigen and antibodies 
through the agarose gel, a streak or band-like precipitate (precipitin line) would form between 
wells of the antibody and antigens, which indicated a corresponding binding of the antibody and 
antigen. Although the antibody was typically positioned in the center well to be surrounded by 
peripheral wells containing different types of antigens, the antibody and antigen arrangement 
was interchangeable, and a known antigen could be used to distinguish binding characteristics 
among antibodies. 
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The double disk diffusion assay has been used to identify various components associated 
with E. coli such as enzymes (Lee and Englesberg, 1962), surface proteins (Guinee et al., 1976; 
Isaacson, 1977), enterotoxins (Honda et al., 1981; Klipstein and Engert, 1985; Tsuji et al., 1985), 
and Stxs (Oku et al., 1989). Oku et al., (1989) used a double disk diffusion assay to differentiate 
a Stx2 variant. These authors purified a cytotoxin that was present in an E. coli isolate, which 
was obtained from a patient that had developed HUS. The toxin, along with purified Stx2, was 
analyzed in a double disk diffusion assay for reactivity against anti-Stx2, as well as against anti-
purified toxin. These authors observed a spur formation in both Ouchterlony assays, which they 
interpreted as a partial identity between the two antigens analyzed. 
Likewise, Klipstein and Engert (1985) compared the immunological similarities of E. 
coli, Campylobacter, and cholera enterotoxins with a double disk diffusion assay. Following the 
purification of the toxins, a B subunit antibody was arranged central to the circular placement of 
E. coli, Campylobacter, and cholera toxins in a gel, and partial identity between enterotoxins was 
determined upon observation of spur formations. 
 
Fluorescent labeling of antibodies and bacterial cells 
In addition to double disk diffusion assays, immunofluorescence techniques provide 
researchers with the ability to visibly detect antibody-antigen associations. Fluorescent 
molecules emit the light they absorb at a certain wavelength range that is at a greater wavelength 
than the wavelength that was originally absorbed, which can be analyzed in several ways. It is 
common to fluorescently label antibodies, which can be performed by covalently linking 
fluorescent molecules to antibodies. The presence of functional groups (carboxylic acids, 
aromatic or aliphatic amines, hydroxyl groups, among others) on the antibodies makes 
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fluorescent labeling possible, and often requires conjugation of fluorescent molecules with 
reactive intermediates (esters, acid anhydrates, diazonium salts, isothiocyanates, among others) 
to achieve the covalent interactions with antibodies (Hemmiliä, 1985). Upon incubation of these 
fluorescently labeled antibodies with samples potentially containing a target antigen, a researcher 
can visually determine antigen presence, whether it is with a light microscope or flow cytometry. 
Fluorescent antibody tests can detect microorganisms that cannot be grown on culture media, but 
does not distinguish between dead and living cells (Thomason et al., 1959).  
However, there are several ways that fluorescence can be used to detect living cells, such 
as color formation due to the presence of substrate, as well as DNA labeling techniques. 
Microtiter plates can be used in prevalence assays to detect microorganisms that produce certain 
components, which react with a substrate to produce a visibly fluorescent reaction. A fluorogenic 
compound (4-methylumbelliferone glucuronide (MUG)) has been used to detect E. coli based on 
the research of Kilian and Bulow (1976) that approximately 97% of E. coli produce beta-
glucuronidase, which cleaves MUG to produce a fluorogenic substrate visible under long-wave 
UV light (Kilian and Bulow, 1976; Feng and Hartman, 1982).  
Also, labeling dyes have been used to stain cellular components such as DNA (Bernander 
et al., 1998), as well as antibodies specific for certain antigens. There are several ways to 
enumerate viable cells. Only viable cells possess a membrane potential, and a variety of dyes are 
available to determine cell viability based on this concept. The membrane of a viable cell will 
either take up or resist dyes depending on the structure of a dye. 
 
Solid phase-based immunoassays 
General concepts 
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Immunoassays progressed as it was realized that due to the hydrophobic nature of the 
interaction between an antibody and antigen, either component could be attached to hydrophobic 
surfaces to quantitate the particular antigen-antibody relationship. Antibodies (or antigens) could 
be bound to surfaces such as plastic as a preliminary step in several revolutionizing 
immunoassay formats that involved determining antigen or antibody presence and/or 
concentrations by way of antibody labeling. 
Immunoassays that are formatted in microtiter plate wells (96 well plates are common) 
enabled the simultaneous screening of many samples, a capability that was not available in 
earlier developed immunoassays. In addition to determining the presence of antigen(s) in many 
samples, quantifying antigen(s) in samples became possible by developing a standard curve in 
which predetermined concentrations of an antigen were applied to microtiter plates. By creating 
a standard curve, the concentration of samples could be used to approximate the quantity of an 
antigen in a sample. Once the ability to bind antibodies to solid phase surfaces was developed, it 
was realized that such antibodies could be quantified if some sort of label was attached to the 
antibody that could be detected by external instrumentation. The following sections discuss these 
approaches. 
 
Radioimmunoassay 
The first immunoassay to incorporate labels was developed in 1960 in the form of the 
radioimmunoassay (Yalow and Berson, 1960; Lequin, 2005), and the labels are most commonly 
the radioisotopes 125I and 3H (Greenberg et al., 1977; Frantz and Robertson, 1981; Soergel et al., 
1982; De Boever et al., 1983). Once antibodies were labeled and the unbound radioactivity was 
removed, analysis of the antigen-antibody reaction(s) could be performed with a liquid 
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scintillator counter, which ultimately quantified the particles that were emitted by radioactive 
decay (Chase, 1980; Yalow, 1980).  
 Several concerns were associated with the radioimmunoassay – labeled reagents were 
subject to radiolysis, the radioisotopes possessed a short half life, proper radioactive waste 
disposal was an issue, and the possibility of radioactive exposure was less than ideal (De Boever 
et al., 1983). Shortly after the development of the radioimmunoassay, there was a growing focus 
on the potential use of nonradioactive labels such as enzyme-based chromophore systems as a 
means to indirectly generate a detectable label in an immunoassay reaction (Lequin, 2005). 
 
Enzyme-linked immunosorbant assay 
In 1971, both Engvall and Perlmann, (1971) and Van Weeman and Schuurs, (1971) 
successfully implemented an enzyme label for detection purposes, and this ultimately led to a 
variety of enzyme-associated immunoassay formats (Lequin, 2005). A primary motivation for 
the development of the ELISA was to improve detection methods in a clinical and public health 
setting that at the time used cell culture or radioimmunoassays (Downes et al., 1989). In addition 
to being able to design an ELISA for various antigens, various formats evolved that could be 
employed for antigen detection and quantification. 
One of the most common immunoassay formats that emerged was the enzyme-linked 
immunosorbant assay (ELISA) (Fukal and Káš, 1989). The ELISA is a multistep process 
commonly used to determine the amount of an antigen in samples (McCarthy et al., 2001). In a 
sandwich ELISA, capture antibodies are bound to a solid surface (typically a 96-well microtiter 
plate) followed by a wash step to remove unbound antibodies. Sample dilutions containing the 
putative antigen are subsequently added to interact with the plate-bound capture antibodies. 
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Following incubation, a wash step is performed to remove unbound antigen. Lastly, a detection 
antibody is added to interact with an available epitope of the bound antigen. It is common 
practice for the detection antibody to be bound to an enzyme. Van Weeman et al., (1971) 
successfully conjugated the enzyme horseradish peroxidase (HRP) to the human chorionic 
gonadotropin (HGC) antigen (Van Weemen and Schuurs, 1971). The HRP enzyme is still 
commonly used in ELISA’s, and is popular in part due to its high turnover number and its small 
molecular size (Gosling, 1990). Alkaline phosphatase, and beta-D-galactosidase are also 
common labeling enzymes that can be used in ELISA assays, and numerous other available 
immunoassay labels have been reviewed extensively elsewhere (Gosling, 1990; Kricka, 1994). 
Following incubation and a wash step to remove unbound antibody-enzyme complexes, an 
enzyme-specific chromogenic soluble substrate is applied. For example, 4-nitrophenyl phosphate 
can be used as a substrate to conjugate alkaline phosphatase. This enzyme-substrate hydrolysis 
reaction results in a color change (peak absorbance of 400 nm) of the solution (Voller et al., 
1976), and is in direct correlation with antigen presence (Hegde et al., 2012a). 
Although ELISA’s have been implemented to detect certain STEC serogroups, it became 
common to design an assay to detect Stx as a screen for all STEC (Kehl et al., 1997). Skinner et 
al., (2013) developed a sandwich assay for an E. coli Stx2 subtype known as Stx2f (Skinner et 
al., 2013). These authors noted that very few assays were capable of detecting the Stx2 subtype 
Stx2f toxin protein, which is one of the seven known Stx2 subtypes (Skinner et al., 2013). The 
Stx2f toxin is not known to be associated with serious human disease (Melton-Celsa, 2014), but 
the assay could be useful to indicate the presence of uncharacteristic phages and plasmids in 
isolates of E. coli (Skinner et al., 2013). Before an immunoassay for the Stx2f toxin was 
developed, monoclonal antibodies were generated by immunizing mice with a Stx2f A subunit, 
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and the splenocytes from the mice were fused with myeloma cells. Following fusion of 
hybridoma cells and screening antibodies for reactivity with Stx2f, four Stx2f specific antibodies 
(designated Stx2f-1, Stx2f-2, Stx2f-3, and Stx2f-4) were found to be specific for the Stx2f toxin. 
The optimal sandwich ELISA format was determined to be with Stx2f-1 as the capture antibody, 
and Stx2f-4 as the detection antibody, which exhibited a detection limit of 0.123 ng/mL of 
purified toxin. These authors suggest that although catch-all assays are useful for monitoring 
food systems, subtype-specific assays would be valuable for tracking Stx subtypes and stx 
encoding phages among microorganisms (Skinner et al., 2013).  
The Premier EHEC Assay (Meridian Diagnostics Inc., Cincinnati, Ohio) is a 
commercially available alternative to conventional culture that has been promoted for detecting 
the presence of Stxs in samples. In 1997, the Premier EHEC Assay was used to screen for the 
presence of Stx(s) in 974 stool specimens in an ELISA format (Kehl et al., 1997). Stool 
specimens were enriched overnight, and 50 µL of the overnight cultures were added to wells 
containing 200 µL of diluent for enzyme immunoassay testing. Following the reaction of stool 
specimen culture and diluent, samples were considered positive if the optical density (450 nm) 
was equal to or greater than 0.150. In comparison to conventional culture, the Premier EHEC 
Assay was determined to be more sensitive (100%) than conventional culture on sorbitol-
MacConkey agar (60 %). This sensitivity was calculated by dividing the number of samples 
detected as positive by the total number of samples that contained Stx (Kehl et al., 1997).   
Downes et al., (1989) developed an ELISA to distinguish between Stx1 and Stx2 for 
evaluating culture and stool specimens. First, monoclonal antibodies (each specific for Stx1 and 
Stx2 toxin proteins) were bound to microtiter plate wells as the primary antibody to capture Stx1 
and/or Stx2. Next, a blocking step was performed to remove unbound monoclonal antibodies, 
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and culture or stool samples were distributed among wells to interact with the monoclonal 
antibodies for a one-hour incubation period. A wash step was performed to ensure that unbound 
Stx(s) were removed from the wells (ideally, only bound antigen would interact with a secondary 
antibody as unbound antigen(s) could compete with the administered secondary antibody if it 
were removed by washing). Following the washing step, two types of polyclonal antibodies 
(each specific for Stx1 or Stx2) were added to the corresponding wells to bind either Stx1 or 
Stx2. An additional washing step was performed to remove unbound polyclonal antibodies, and 
alkaline phosphatase-labeled anti-rabbit antiserum was added to each well, followed by a 
washing step. After an incubation period to allow an enzyme-substrate interaction, a stop 
solution was added to inhibit additional color development, and the optical density was measured 
to determine the presence of Stx1 and Stx2. Both ELISA’s exhibited 100% specificity, and it was 
suggested that the detection limit for the Stx1 ELISA was 200 pg of purified Stx1, and the 75 pg 
of purified Stx2 for the Stx2 ELISA. These authors noted that the Stx2 ELISA was the first to 
specifically target Stx2, and that detecting both Stx1 and Stx2 was considered necessary to 
confirm the presence of STEC (Downes et al., 1989). 
A more recent study suggests certain types of Stx proteins may be undetectable with 
ELISA’s that were designed to specifically target Stxs (Willford et al., 2009). The performances 
of three commercially available ELISA kits (Premier EHEC test (Meridian Bioscience Inc., 
Cincinnati, OH), the ProSpecT Shiga toxin E. coli (STEC) Microplate Assay (Remel Inc., 
Lenexa, KS), and the Ridascreen Verotoxin Enzyme Immunoassay (r-Biopharm AG, Darmstadt, 
Germany) were evaluated for the ability to detect Stx variants (Willford et al., 2009). Each 
ELISA kit was conducted as a sandwich format, and positive results were recorded by visual 
observation or by an optical density measurement. The type of Stx(s) in each sample was 
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determined by PCR. The detection limit of the Premier EHEC test and the Ridascreen Verotoxin 
Enzyme Immunoassay was established as 106 CFU/mL, and 107 CFU/mL for the Ridascreen 
Verotoxin Enzyme Immunoassay, respectively. Two Stx variants that were PCR-confirmed were 
shown to be undetectable by all three evaluated ELISA kits. The authors suggested the STEC stx 
genes might not have been detected due to mutations within the opening reading frames of these 
genes, which would result in a non-functional gene protein product that was structurally altered 
enough to no longer be recognized by the antibody generated against the original toxin protein 
structure (Willford et al., 2009). 
There are other instances that also suggest an ELISA assay may be inefficient in 
detecting all STEC – in 2013, of the 632 stool specimens that were tested for the presence of 
STEC, twenty one samples were positive. While all of the twenty one positive stool samples 
were detected by PCR, only six were detected by ELISA (Vallières et al., 2013). The results 
indicated that the presence of STEC by PCR, that resulted in false negatives with ELISA, were 
likely due to the fact that PCR has shown to exhibit a sensitivity that is 104 CFU/mL greater than 
ELISA based assays (Vallières et al., 2013). 
To improve ELISA techniques, modifications and variations have been developed. For 
example, Galikowska et al., (2011) utilized bacteriophages to serve as the initial capture 
components for various strains of Salmonella enterica and E. coli in a variation of an ELISA 
format (Galikowska et al., 2011). The ELISA sandwich format was performed as usual, except 
that instead of initially coating wells with capture antibodies; phages (108/well) were adsorbed to 
the polystyrene surface of ELISA plate wells. Following the conventional incubation, blocking, 
and washing steps with the subsequent addition of antigen, capture antibody, and labeled 
enzyme, the sensitivity of the bacteriophage-based ELISA assay was determined to be 106 
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cells/mL, which is similar to other ELISA assays that involve coating primary antibodies to a 
solid phase (Galikowska et al., 2011). 
Bacteriophages are attractive capture components due to the multivalent interaction(s) 
with host cells, and Petrenko and Vodyanoy, (2003) suggested that there are thousands of 
binding sites/particles on the bacteria that are associated with a phage (Petrenko and Vodyanoy, 
2003). Bacteriophages can be implemented in various detection assays, and a wide range of 
potential applications have been reviewed (Singh et al., 2013; Arugula and Simonian, 2014; 
Schmelcher and Loessner, 2014). 
Regardless of the capturing components utilized in an ELISA, this may not be the best 
available method for determining the presence of STEC. Also, the ELISA is a laborious 
technique (requires several wash and incubation steps), takes several hours (Teel et al., 2007), 
and is not likely to be implemented for pathogen detection in the food industry, especially as a 
stand-alone assay. 
Immunoassays that can be analyzed visually are also available, and since the assays are 
generally easy to perform, they are useful for clinical laboratories to determine further detection 
approaches and treatment. Additionally, immunomagnetic separation beads can be used on the 
front end of an assay to extract microorganisms from samples, which helps reduce the sample 
volume and concentrate target cells. Immunoassays that can help visually identify, as well as 
concentrate target cells will be discussed in later sections of this review. 
Additionally, lateral flow (dipstick) immunoassays are simple and cost effective 
immunoassays that are available for prompt analysis of a sample for Stx(s), as well as STEC(s) 
(Aldus et al., 2003; Willford et al., 2009; Noguera et al., 2010), and these have been extensively 
reviewed (Posthuma-Trumpie et al., 2009; Sajid et al., 2014; Zhu et al., 2014). 
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In addition to being at the forefront for implementation in food systems, immunoassays 
and immuno-based sensors are also being investigated for biomedical applications (Wu et al., 
2007). Certainly, immuno-based sensors have the potential to be incorporated in food detection 
systems. These techniques have been discussed and described extensively (Ricci et al., 2007; 
Yang and Bashir, 2008; Tokarskyy and Marshall, 2008; Clotilde et al., 2011; Zhu et al., 2014) 
and therefore will not be discussed further in this review. 
 
Latex agglutination 
Antibody specificity (Hegde et al., 2012b), as well as the presence of pathogens in mixed 
microbial populations can be determined by coating latex particles with target antibodies in a 
process known as latex agglutination, which is the most common clinical laboratory method used 
for O antigen identification (Atkinson et al., 2012). Latex-bound antibodies form a complex with 
any antigen present in a sample to form visually identifiable precipitates (De Boer and 
Heuvelink, 2000). 
A microtiter plate format has been utilized with a latex agglutination assay to detect the 
Stx1 and Stx2 toxin proteins (Karmali and Petric, 1999). Briefly, polyclonal antibodies (specific 
for Stx1 and Stx2) were bound to latex particles, and applied to wells containing human isolates 
that potentially contained STEC. Following a 24-hour incubation period, Stx presence and the 
antibody titer was determined (Karmali and Petric, 1999). Titer is often determined by observing 
the most dilute sample that results in a positive reaction. Such an assay could provide useful for 
epidemiological (Karmali and Petric, 1999), as well as clinical information due to the fact that 
Stx2 has been shown to be more virulent than Stx1 (Tesh et al., 1993; Vallières et al., 2013). 
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Determining the type of Stx isolated from a patient may lead to a different treatment (possibly 
closer monitoring for HUS for patients with Stx2-containing stool). 
Additionally, a method known as the Optical Immunoassay (OIS) is available for visual 
identification of microorganisms. The BioStar OIA SHIGATOX kit (Inverness Medical 
Professional Diagnostics, Inc.) can be used to visually identify the presence of Stx1 and Stx2, but 
this method does not distinguish between the two toxins (Teel et al., 2007). A mixture of anti-Stx 
antibodies (specific for either Stx1 or Stx2) is coated to a silicon wafer. After addition of a 
sample, secondary anti-Stx1 and anti-Stx2 antibodies are added to the sample. The light 
reflection from the silicon wafer typically appears gold, but in samples containing Stx, the 
thickness of the wafer increases, which causes an altered light reflection that appears purple 
(Teel et al., 2007). The OIS can be analyzed in less than 20 minutes, and can be visually 
determined positive by observing color development. The performance of the OIA SHIGATOX 
assay was similar to that of the Premier EHEC assay when screening frozen and broth-enriched 
samples. However, the sensitivity of the OIA SHIGATOX test (96.8%) was superior to the 
Premier EHEC assay (83.9%) when screening fresh direct stool samples (Teel et al., 2007).  
 
Multifunctional immunoassays for separation and detection 
General concepts and the issue of sampling 
Knowing the true population or presence of a cell type is difficult due to the fact that the 
sampling strategy presents a problem for pathogen detection. In general, only a small portion of a 
product is sampled for microorganisms, and conclusions about the total product have to be made 
based on results from this small sample size. Techniques that condense a cell population from a 
sample enable the possibility that a larger sample per product can be tested to achieve a better 
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cell population estimate. Filtration and centrifugation procedures are common approaches that 
can be used to concentrate cells in a large sample volume, while also removing unwanted debris 
and components in food and environmental samples. Although optimizing cell concentration 
methods seems to be appropriate, one must also consider that food producers will not likely test 
larger sample quantities of each product to circumvent product loss due to sampling. Aside from 
such considerations, methods that are proven to condense or concentrate cell populations in 
samples will aid the sampling process – concentrating cells will result in a reduced volume size 
that is generally easier to work with during sampling procedures. 
Designing a representative collection protocol is mostly a statistical exercise based on 
estimating the likelihood of isolating the pathogen within the logistical constraints of sampling. 
However, developing high-throughput sampling systems that can accurately reflect the desired 
statistical goal is a technological challenge. Certainly a number of molecular methods can be 
used for the final detection steps, but the true challenge is collecting enough representative 
samples to have confidence in the outcome. 
The practice of quantifying antigens with immunoassays such as ELISA is useful for 
many applications, but the availability of antibodies and their well characterized affinity 
properties have led to their use not just for detection, but initial capture from sample matrices. 
This concept has been employed as the basis for emergence of an entire line of technological 
developments for utilizing antibodies to capture or sequester target antigens from complex 
matrices. This has in turn led to new approaches for sampling. 
This has fostered advancements in antibody construction to generate antibody complexes 
with iron for ease of separation due to magnetic employment separation. Immunomagnetic 
separation can be used to limit the duration of enrichment, concentrate low cell populations 
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dispersed in a large sample volume, and ultimately reduce a sample volume to a more workable 
form that can be analyzed employing advanced detection systems. More complex approaches 
have ushered in an array of specialized cell separation equipment that does not rely on magnetic 
properties of specifically constructed antibody complexes, but are capable of recognizing 
individual antibody-antigen complexes. These are discussed in the following sections.  
 
Magnetic immuno-beads 
Immunomagnetic separation is used to recover target microorganisms from samples by 
applying magnetic beads bound to antibodies (Veal et al., 2000). Samples are mixed with 
antibody-bound magnetic beads for a short period of time (approximately 10 minutes). A 
separator that produces a magnetic field is used to recover the bacteria that are bound to the 
antibody-bead complex (Auvray et al., 2007). Recovered beads are washed, enriched, and spread 
on plates for follow-up incubation and eventual enumeration (Seo et al., 1998; Varela-Hernández 
et al., 2007; Çadırcı et al., 2010). Immunomagnetic separation is gaining considerable attention 
as a necessary step in the pathogen detection process (Potter, 2014), and as a result, automated 
IMS methods have been developed (Chen et al., 2014). 
A potential application for the food industry would be to apply a capture antibody or 
antibodies that binds all E. coli in a sample. Such a step would reduce sample volume as well as 
background noise associated with food matrices. Following separation, these cells could be 
further analyzed with an instrument capable of measuring individual cells. A capture antibody 
would need to target live and intact whole cells given that only live cells will lead to human 
illness. Whole cell detection would be applicable by targeting an exposed target such as a 
universally expressed surface protein. Consequently, antibodies would only bind to cells with an 
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intact membrane, which is more likely representative of living cells (Riedy et al., 1991). This 
would also eliminate false positives that can occur with the inclusion of intracellular detection 
targets. Intracellular components could still be bound once a cell is lysed, which would not be the 
case for an epitope present on an intact membrane. Finding an extracellular commonality of all 
E. coli would be considered the first step in the development of an antibody that could bind to all 
E. coli. The efficiency of such an assay would depend on the consistent accessibility of the 
universal epitope, continuous expression of the protein under all growth conditions, along with 
the antibody sensitivity and specificity to the epitope. This would likely involve analysis of 
binding efficiencies for each type of samples (different food matrices) in which the assay would 
be applied. 
 
Flow cytometry 
Basic concepts 
Flow cytometry has been applied to a wide range of scientific fields since the idea was 
first described in 1934 (Moldavan, 1934), and there are a variety of flow cytometers currently 
available (Table 2). A flow cytometer is used to analyze a population of cells by determining the 
percentage of cells in a population that are of a certain size, composition, or that express a 
particular antigen of interest. In addition to identifying cells of certain types, flow cytometers can 
be programmed to separate cells that exhibit distinct characteristics. It is common to 
fluorescently label antibodies that are specific for an antigen/surface protein of interest, and such 
approaches for labeling were discussed in a previous section. The first successful cell separation 
technique was performed in 1965 (Fulwyler, 1965) when multiple scientific disciplines were 
combined to adapt the droplet sorting technology used in ink jet printers (Davey and Kell, 1996). 
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This technique was made possible due to the ability of the cell sorter to recognize and sort target 
cells based on similar features such as size, density, membrane potential, adherence ability, and 
fluorescence (Herzenberg et al., 1976). The technology was essentially based on droplets of cells 
becoming electrostatically charged after being passed through two high voltage plates, and cells 
with different characteristics subsequently being deflected into their respective receptacles 
(Holmes et al., 2014). 
Herzenberg and Sweet, (1976) first described fluorescence-activated cell sorting (FACS) 
nearly 40 years ago where they discussed the advances such a tool would bring to molecular 
biology due to the ability to sort cells by phenotypic similarities. Employment of a FACS 
approach allows for retrieval of homologous microbial cell populations from samples containing 
heterogeneous organisms. If fluorescently labeled antibodies specific for an antigen were applied 
to a sample, in theory, any cells containing the target antigen could be detected in the sample, 
and subsequently separated into a uniform population of cells. FACS can be a useful tool for 
obtaining homogeneous populations when the objective of studying a particular organism and/or 
phenotype is desired. 
 
Instrumentation 
Flow cytometers rapidly analyze individual cells (i.e. particles in a suspension), one cell 
at a time, and samples can be analyzed within seconds. The degree at which light interacts with 
these particles reveals detailed output on the population of cells in a suspension. Cells are passed 
by a laser in single-file fashion and are intersected by a laser for a period of approximately 0.2 to 
4 µs. Individual cells scatter light depending on size, internal complexity, and fluorescence 
emission. Lenses collect and focus the light on to light detectors; diffracted light in the same 
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direction as the laser (forward scatter) represents cell size, and refracted and reflected light at a 
90° angle (side scatter) represents internal complexity (Bernander et al., 1998; Givan, 2004). An 
event is considered any type of an observed particle (Wood, 2001; Givan, 2004). There is a 
relationship between flow rate and the probability that more than one particle is identified as an 
event, and with more concentrated samples there is a greater likelihood that events will be 
missed and therefore underestimated (Givan, 2004). The process of acquiring the proper events 
for analysis is known as gating, and a detailed description of this complex process is available 
(Wood, 2001). Proper gating assures that formulated data from a sample are a product of viable 
target organism cells (Herzenberg et al., 1976). Since events that are not representative of a 
target organism will likely be counted, gates can be set for multiple factors such as forward 
versus side scatter and green versus red fluorescence. Gates consist of thresholds that although 
detected, will exclude the irrelevant events, and the events inside the gate will only be considered 
in analyses. Although it may take several trials to determine the proper gating parameters for a 
particular protocol, once formulated, these gates can assure final analyses will account for only 
the target organism. 
Along with analyzing forward and side scatter parameters, multi-dimensional flow 
cytometers can analyze parameters with the use of fluorescent labels that emit light when 
exposed to certain wavelengths. The laser most commonly used in flow cytometers is the 488 nm 
argon laser (Givan, 2004), and more than one laser is available in advanced flow cytometers for 
multifluorescent analysis (Herzenberg et al., 2002). The contrasting fluorescence emitted by 
fluorochromes enables characterization of multiple cellular components (parameters) within an 
analysis (Givan, 2004). Bacteria cannot always be identified with forward and side scatter 
parameters due to their small size (Bernander et al., 1998), and fluorescently-labeled antibodies 
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represent a more reliable approach (Wood, 2001). Technical improvements are still being made 
for prokaryote research with fluorescently labeled antibodies and nucleic acid binding dyes 
(Wood, 2001; Müller and Nebe-von-Caron, 2010). 
 
Fluorescent sources 
Propidium iodide is a common dye used to stain dead bacterial cells (Subires et al., 
2014), and Syto 9 can be applied to label viable bacteria prior to analysis in a flow cytometer 
(Duncan et al., 2006). In theory, cells with a compromised plasma membrane will take up 
propidium iodide, and be identifiable in a flow cytometer as dead cells (Díaz et al., 2010). By 
labeling the dead cells with propidium iodide, the number of viable cells can be calculated by 
subtracting the dead cell events (outside a predetermined gating parameter) by the total events. 
Although propidium iodide can give indication of cell viability, it is often applied in conjunction 
with other labeling dyes, and there have been instances of live cells being mislabeled (Díaz et al., 
2010; Buzatu et al., 2013). Syto 9 dye has been used with propidium iodide, and Syto 9 labels all 
the cells in a population as green, while cells consisting of Syto 9 and propidium iodide emit a 
red fluorescence (Rudi et al., 2005). 
Other methods of cell labeling methods are available. For example, apple juice, milk, and 
food samples containing non Stx-producing E. coli O157 and E. coli K-12 have been analyzed 
with an EPICS ELITE flow cytometer by double-staining cells with 5-cyano-2, 3-ditolyl 
tetrazolium chloride (CTC) and fluorescein isothiocyanate (FITC). A CTC approach enables 
analysis of the respiratory activity in bacteria, and FITC is a fluorochrome used for antibody 
labeling. CTC and the FITC-labeled antibody are detectable due to the characteristic red and 
green fluorescent signals emitted by each component, respectively. To compare the efficiency of 
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the method, 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) was utilized to counterstain 
CTC and FITC stained samples, which were enumerated with an epifluorescent microscope 
(Yamaguchi et al., 2003). These authors reported that the optimal conditions for CTC staining 
was a 30 minute sample incubation at 37 °C in a CTC concentration of 2 mM. The efficiency and 
application of similar dyes have been reviewed previously (Müller and Nebe-von-Caron, 2010; 
Elizaquível et al., 2014). 
 
Clinical and industrial flow cytometry applications 
The breadth of research with flow cytometers is extensive; research includes the study of 
eukaryotes, drug development, enumerating bacteria (Clarke and Pinder, 1998; Comas-Riu and 
Rius, 2009), determining cell size (Skarstad et al., 1983), shape, density, and cell cycle kinetics 
(Steen et al., 1982) among others (Jaroszeski and Radcliff, 1999; Müller and Nebe-von-Caron, 
2010). Flow cytometry has also created an avenue for characterizing the morphology of cells, a 
practice extremely difficult to do microscopically. More recently, the effect of certain enzymes 
on the morphology of E. coli cells has been investigated (Meberg et al., 2004; Laubacher et al., 
2013). 
Flow cytometry has also been used to determine the effect of diet on host susceptibility to 
Stxs by detecting the presence of Stx receptors (Gb3) on the surface of human colonic epithelial 
cells (Zumbrun et al., 2013).  Human colonic epithelial cells that were exposed to sodium 
butyrate (characteristic of a high-fiber diet (HFD)) exhibited a ten-fold increase in Gb3 levels 
compared to cells with no treatment. Follow up experimentation included comparing the number 
of Gb3 receptors in HFD mice to low fiber diet (LFD) mice, which revealed that the HFD mice 
possessed significantly more Gb3 receptors. Lastly, HFD and LFD mice were infected with E. 
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coli O157 and HFD mice exhibited a greater level of infection as well as lesions (Zumbrun et al., 
2013). This work demonstrates that flow cytometry could be used to provide strong support for 
results that were acquired with different methods such as immunofluorescence tissue and cell 
staining, cytotoxicity assays, and gas chromatography due to the ability of analysis at the cellular 
level with flow cytometry (Zumbrun et al., 2013). 
Hegde et al., (2012b) determined the required duration time for enrichment (6, 8, or 12 
hours) to detect STEC in artificially spiked ground beef samples via flow cytometry. Ground 
beef samples were spiked with each of the “big six” STEC serogroups, enriched, and analyzed 
by both aerobic plate enumeration and flow cytometry. Prior to analysis of the spiked samples 
with a flow cytometer, polyclonal antibodies were raised in rabbits against heat-killed whole 
cells for each of the “big six” STEC serotypes. These polyclonal antibodies were subsequently 
fluorescently labeled with the Alexa Fluor 488 label from the Zenon rabbit IgG labeling kit 
(Molecular Probes), and mixed with 200 µL of bacterial cells, and incubated for 1 h at room 
temperature to allow the fluorescently-labeled antibodies to bind the respective STEC cells. 
Following 3 washes with phosphate buffer saline, samples were analyzed in a Beckman Coulter 
FC500 flow cytometer (Hegde et al., 2012b). These authors concluded that the flow cytometry 
assays could detect spiked samples after 8 h of enrichment, except for serotypes O45 and O103, 
which could be detected after 6 h of enrichment due to an accelerated growth rate. The 
relationship between the percentage of detected cells via flow cytometer and cell number based 
on aerobic plate count exhibited a regression coefficient of 0.9809, and these authors reported 
that the detection limit of the flow cytometry protocol ranged from 1 to 10 CFU (Hegde et al., 
2012b). 
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Wilkes et al., (2012) and Buzatu et al., (2013) utilized the recently developed RAPID-B 
model 9013 flow cytometer (LITMUS RAPID-B, LLC, Little Rock, AR) flow cytometer to 
detect E. coli O157:H7 in several food matrices. Wilkes et al., (2012) determined the detection 
efficiency and levels of background noise associated with fifteen food systems, and Buzatu et al., 
(2013) investigated ways to limit the autofluorescence caused by food particles in fresh spinach. 
These authors optimized RAPID-B protocols for various food systems to meet the goal of 
attaining sample results within an 8 hour production shift (Wilkes et al., 2012; Buzatu et al., 
2013). Wilkes et al., (2012) investigated several options for background noise reduction; 
optimizing growth conditions for E. coli O157:H7, filtration, centrifugation, oxygen bleaching, 
and gating optimization (Wilkes et al., 2012). These authors determined the most appropriate 
background noise reduction procedures for each food sample. For example, 500 000 false 
positive counts were observed in ground beef samples prior to background noise reduction 
procedures. However, following two cycles of centrifugation, decanting the supernatant, 
suspension with PBS, and diluting with PBS, only one false positive count was observed. In 
addition to reducing background noise, high speed centrifugation and subsequent sample 
dilutions enabled target bacteria to become more concentrated, and increased the sensitivity of 
the protocol (Wilkes et al., 2012). 
Buzatu et al., (2013) determined that phyloxine B was a sufficient photobleaching agent 
to reduce background noise associated with spinach, and that the limit-of-detection for the 
optimized RAPID-B assay to detect E. coli O157:H7 in spinach was 1 viable cell per 25 g of raw 
spinach (Buzatu et al., 2013). More recently, Buzatu et al., (2014) further optimized a pathogen-
specific detection system with the RAPID-B model 9013 flow cytometer (Vivione Biosciences, 
LLC, Pine Bluff, AR). With this assay, live and dead cells can be enumerated, and 15 to 20 
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samples could be analyzed per hour (Buzatu et al., 2014). These authors compared the cell 
counts of E. coli O157 between conventional plate counts and RAPID-B flow cytometry 
analysis. Subsamples were analyzed in duplicate for each method, and results indicated 10 to 50 
percent greater counts were observed with the RAPID-B assay compared to plate count methods. 
In addition to greater cell recovery, these authors emphasized that the RAPID-B system could be 
performed over an 8 hour time period, while the conventional plating method would have 
required a time span of 48 to 56 hours (Buzatu et al., 2014). 
Comparison between flow cytometers can be difficult due to differences in configuration, 
operating conditions, lasers, and setting variations (Bernander et al., 1998). The lack of 
standardization is problematic, and until a system is validated, there will be a need to optimize 
research protocols in accordance with the flow cytometer system, antibodies, and labeling 
reagents on hand to target microorganisms. Moreover, performance tests to optimize flow 
cytometry protocols need to be conducted by inoculating foods such as ground beef with known 
quantities of STEC versus natural contamination. To further support bacterial counts as 
determined by flow cytometry, additional procedures to compare bacterial counts are often times 
appropriate. For example, in addition to analysis of samples via flow cytometry, a fluorescent 
microscope can be used to visually analyze bacterial populations. Fluorescently labeled 
polystyrene beads can be applied to samples to interact with target cells. Once target cells are 
bound, these cells can then be enumerated in a hemacytometer via fluorescence microscopy. 
Upon enumeration of target cell populations in samples by flow cytometry, the ratio of flow 
cytometer counts to fluorescent microscopy counts can subsequently be calculated to determine a 
regression coefficient among cell populations, and provide a more supportive enumeration of 
cells (Tortorello et al., 1997). 
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The need for low cell detection and high sensitivity in STEC protocols makes reduction 
of background noise an important hurdle to address. Before analyzing samples in a flow 
cytometer, samples are typically filtered to remove as much debris as possible (Hegde et al., 
2012a, 2012b; Wilkes et al., 2012) due to the possibility of large particles clogging a flow 
cytometer. Background noise can result in a dead time due to excessive and undesired signals, 
and methods to reduce background noise have been reviewed (Stevens and Jaykus, 2004). 
Additionally, problems can arise when analyzing plant-based samples in conjugation with 
markers that emit green fluorescence when excited by lasers. These foods contain components 
capable of fluorescently emitting light and reducing detection sensitivity. Sodium bicarbonate 
has been applied to limit background noise from light emitting molecules (Buzatu et al., 2013), 
but its corresponding use is application dependent. Sodium bicarbonate can compromise cell 
membranes, making propidium iodide no longer applicable for distinguishing viable from 
nonviable cells (Wilkes et al., 2012). Storage time has proven to influence the detection ability 
with flow cytometry, especially of injured cells (Subires et al., 2014). 
If flow cytometry protocols that are designed for STEC become reliable and validated, a 
flow cytometer could become a staple for quality and assurance in the food industry. An 
individual sample can be analyzed within seconds, which suggests that flow cytometry could be 
an instrument for analyzing large numbers of samples in a work shift following sample 
preparation (incubation, washing, target labeling, among others). Also, once a protocol becomes 
repeatable, and meets regulatory standards, there is potential for automation of the 
instrumentation, which creates an avenue for even more high-throughput technology. Since there 
are potentially several benefits including cost savings in personnel time if flow cytometers are to 
be more routinely employed in commercial settings such as food testing laboratories, it will be 
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necessary to address issues that can arise due to pathogen adaptation(s), as well as how to 
promptly detect emerging pathogens, which will be discussed in the following sections. 
 
Future directions and developments for immunoassays and E. coli  
General issues 
Considering the reactionary-based history of the regulatory adaptation processes for food 
testing procedures in the USA, it is likely that as new serovars continue to emerge and once 
again ignite public health concerns, this will in turn lead to a longer and longer list of serovars 
that eventually become defined as adulterants. If such instances reoccur, more readily adaptable 
assays that can be implemented for new serovars will become critical, and understanding the 
nature of antibodies, and the practical means that they can be used to detect emerging serovars 
will aid in the process of adapting and eventually implementing an assay. Similar to currently 
available immuno-based methods, several issues will remain to be addressed due to the antibody-
antigen interaction variations in different environments (food matrices, stool samples, among 
others).  
 
Optimizing the antigen-antibody relationship 
Assays performed in different food systems may not necessarily have similar levels of 
efficiency. It is difficult to compare assays due to varying consistencies (powder, paste, or liquid) 
and processing conditions among food systems (Fukal and Káš, 1989). In addition, the use of 
different sources of antibodies makes immunoassays difficult to compare due to the differing 
affinities of antibodies for antigens. One cannot state that one assay is better than another unless 
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identical antibodies and antigens are used in both assays. For this reason, antibody performance 
must be systematically evaluated for a variety of assays and food systems. 
As previously described, the variable region of an antibody is responsible for binding an 
antigen. A sequence of roughly fifteen amino acids in the variable region will physically 
associate with an epitope (Frank, 2002). There are potentially numerous combinations of the 
fifteen amino acid sequences that can form a binding site, many of which overlap one another, 
thus providing the potential for interacting with many epitopes in a variable region (Frank, 
2002). 
These potential sequences bind an antigen at different affinity levels, which can result in 
cross reactivity and false positives (Frank, 2002). Antibodies produced against one antigen may 
interact with a structurally related epitope of a different antigen and is commonly referred to as 
cross reactivity, which is the interaction of an antibody with a different antigen(s) than the 
antibody was intended (Frank, 2002; Abbas et al., 2012). The inclusivity of a detection method is 
defined as the percentage of target organisms that are recognized in an assay, while exclusivity is 
defined as the percentage of non-target organisms that are falsely recognized by an assay. Target 
organisms are defined based on relatedness (such as taxonomic, immunological, or genetic 
composition) (FDA, 2011). For example, by applying an antibody that targets antigen A, a 
desired assay will be 100% inclusive (all antigen A in a sample will be recognized), and 100% 
exclusive (all antigens besides antigen A will not be recognized).  
Theoretically, any antibody molecule can cross react and bind a different antigen. Such 
circumstances are a troublesome reality for general antibody use for detection and quantitation 
due to the misleading conclusions (false positives). Therefore, it is necessary to determine the 
cross reactivity of antibodies among antigens to determine the likelihood of implementing an 
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antibody (or set of antibodies) in a detection application. Immunoassays such as latex 
agglutination and ELISA can be used to estimate cross reactivity (Medina et al., 2012). For 
example, certain antibodies that target E. coli O26 are known to also interact with strains of E. 
coli O103 (Medina et al., 2012). 
The availability of an epitope for antibody binding can be dependent on the state of the 
molecule that possesses the antigenic determinant. One type of antigen epitope (conformational 
epitope) becomes inaccessible following protein denaturation (Abbas et al., 2012). Quality 
control steps during food processing can alter microorganisms without complete destruction, 
which can lead to protein denaturation and the loss of epitope availability. One way to overcome 
an inaccessible antigenic determinant would be to apply an additional antibody that binds to a 
site accessible after protein denaturation (linear determinant). Applying more than one antibody 
would in theory increase the sensitivity of an assay, regardless of the structure of the target 
protein. 
Deciding on the antibody to use can be complicated, and the ultimate decision comes 
down to how the antibody will be applied (Lipman et al., 2005). Optimizing an antibody and 
immunoassay for pathogen detection would likely be dependent on the accuracy, sensitivity, 
repeatability, and feasibility of an antibody and assay. With these characteristics in mind, 
determining the most appropriate immunoassay would likely involve analyzing the optimal 
antibody sensitivity in different immunoassays. Consequently, understanding of the antibody-
antigen interaction, as well as establishing the target epitope of an antigen would be considered 
necessary. Although most researchers take advantage of readily available commercial antibodies, 
there are tools available to determine epitope uniqueness of target organisms. 
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Identifying and optimizing unique antigen targets 
Depending on the target organism (or target antigen) for an assay, an optimal antibody 
may not be available or in existence. By sorting through the genome sequences of many 
organisms, a researcher can locate an antigen sequence unique to the target organism that could 
potentially be used to produce an antigen-specific antibody that was not previously available. 
The Basic Local Alignment Search Tool (BLAST) is a program available to researchers on the 
National Center for Biotechnology (NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
BLAST can be used to identify nucleotides and proteins that are unique to the target organism. 
The genomes of a wide range of organisms have been sequenced and are available as a library on 
the NCBI website. A BLAST search can be used to make genetic comparisons between 
organisms, whether it is DNA similarities based on nucleic acid sequences or protein similarities 
based on amino acid sequences. During a search, all known genomes with similar protein or 
nucleotide sequence(s) are typically scanned to provide a comprehensive data set on which 
organisms also possess a certain cellular component, and to what extent. 
There are different ways to conduct a BLAST search. It is common practice to search 
with BLAST to develop PCR primers that are useful in identifying specific genes or organisms 
of interest. An example would be adding the nucleic acid sequence of a bacteria and searching all 
known organisms with similar DNA, thus possibly delineating any uniqueness that could be used 
in primer development. Primer development with BLAST is particularly useful for conventional 
multiplex PCR to distinguish closely related species of microorganism. Since protein sequences 
can also be compared among organisms, a BLAST search could easily serve as a starting point 
for antibody development for whole cell detection by determining the amino acid sequence of an 
extracellular epitope either shared by all E. coli or epitopes highly specific to one serotype. 
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Extracellular protein data is readily available in the literature and can include accession 
numbers of the organism(s) possessing such proteins. By inserting the accession number and 
protein name into the NCBI search bar, information on the organism, protein sequence, and other 
organism protein sequences becomes available. Also, by inserting a protein sequence into a 
BLAST search (protein blast), all known genomes can be searched to provide information on 
other organisms that entirely or partially contain the protein sequence. A search is typically 
conducted within a relatively short period time period (typically several minutes), and the search 
page will subsequently reload and provide the “time since input.” Not every known genome has 
to be included in a search, and a search can be performed on a single organism. BLAST search 
results provide a list of organisms in ascending order based on the degree of sequence 
similarities. 
 As of 2011, the genetic clusters of 96 O antigens had been sequenced, and at that time 78 
additional O groups were still being pursued (DebRoy et al., 2011). Determining the genetic 
sequences of O antigens will not only help determine how these genes impact virulence 
mechanisms, but will provide information on any universal structural components between O 
antigens, and will likely be useful for antibody production (DebRoy et al., 2011). 
 
Alternative antibody sources 
Requirements for antibody sources 
With regard to immuno-based systems, deciding on antibodies for a particular application 
involves complex obstacles. Determining the best target location of an antigen needs to be 
carefully considered; specificity, selectivity (Table 3), and reproducibility are important criteria 
to consider when selecting antibodies for assay development (Bordeaux et al., 2010). Antibody 
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development by laboratories is often limited due to high costs, difficulty, excessive labor, and 
time; hence the popularity of commercial antibody sources. 
There are many factors that contribute to the variation of antibody recognition of an 
epitope (assay format, protein conformation, nonspecific binding, among others) (Perkel, 2014). 
To ensure that the properties of antibodies are accurately portrayed, peer reviewed publication 
submission requirements have been laid out to combat publication of poor data from immuno-
based research (Perkel, 2014). When purchasing commercially generated antibodies, possessing 
certain fundamental information about the type of antibody is essential (Saper, 2005). Knowing 
specifically its source, how it has been characterized, the controls used for development, and the 
antigen (and specific sequence) that the respective antibody was raised against are considered 
necessary background information that should be, but are not always, provided by a supplier 
(Saper, 2005). Another driving force for requiring technical antibody information in published 
research articles is due to the difficulty of exactly reproducing similar data, especially if reagents 
and antibody information is not fully provided (Perkel, 2014). There are over 300 suppliers of 
antibodies worldwide (Bird, 2012). In a survey conducted by Frost and Sullivan of which 1155 
subscribers to The Scientist magazine (LabX Media Group, Midland, Ontario, Canada) 
participated, 88% of subscribers claimed antibodies were currently used in their laboratories 
(Bird, 2012), however, antibody sources were not identified. 
 
Issues with current antibody sources 
Although necessary, maintaining a proper environment for animals to remain healthy 
over the duration of their use for research purposes can be represent a tremendous investment in 
labor. For example, designer rodents are more vulnerable to infectious agents, and continuous 
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monitoring and husbandry of animals can require extensive efforts (Cork et al., 1997). Along 
with continuously monitoring the well being of animals, and although animal pain and suffering 
during immunization is typically minimal, there are those individuals and corresponding 
organizations who are universally opposed to the use of animals for research purposes (Hurnik, 
1990; Conn and Parker, 2008), and in response to these concerns, animal welfare has become 
more heavily regulated (Cork et al., 1997; Matheny and Leahy, 2007; Rushen et al., 2011). Any 
incidents that violate the Animal Welfare Act will likely lead to more stringent regulations for 
animal-based antibody suppliers to recognize and prevent any incidents of animal neglect. 
Resistance to heightened regulations could drive animal-based antibody producers out of the 
commercial market following fines, lawsuits, or a perceived reputation for inhumane treatment 
of animals, and it has been speculated that as new technologies emerge, the use of animal-based 
research will likely require even more rigorous justification (Dresser, 1992; Cork et al., 1997; 
Conn, 2009; Rushen et al., 2011; Cossins, 2012). 
In addition to more justification, to avoid confrontation in the animal welfare 
controversy, antibody users will more likely consider employing alternative sources of 
antibodies. Antibody development without animals is possible, and due to the ensuing recent 
publicity of animal abuse with some commercial antibody suppliers (Grant, 2014), alternatives 
would eliminate the growth of an unsettling consumer conscience with regard to the source of 
antibodies. These alternative sources will be discussed in the following sections. 
 
Novel clone libraries and systems specific for antibody production 
Alternatives of antibody sources include modified monoclonal antibody production, 
cloning antibody variants into yeast and bacterial cultures, as well as creating multi-specific 
  
98
antibodies in transgenic plant systems (Plückthun, 1991; Hayden et al., 1997; Brekke and Løset, 
2003; Kipriyanov and Gall, 2004; Berghman et al., 2005; Zeliadt, 2014). An additional process 
of monoclonal antibody production involves isolating B cells by flow cytometry, distributing the 
B cells in 384 well plates, and culturing the B cells in an environment supportive of growth and 
antibody secretion. After two weeks of culture, the secreted antibodies are screened to determine 
their ability to neutralize an antigen. The heavy and light chain(s) of antibodies that show 
neutralizing activity are cloned into expression vectors and are expressed by transfection to 
produce recombinant antibodies (Huang et al., 2013). This method is advantageous in that it can 
be performed in much less time (about 3 weeks) than the typical monoclonal antibody production 
time (3 to 6 months) (Leenaars et al., 1999; Lipman et al., 2005). However, it is believed to be 
more applicable for laboratories with an automated liquid-handling device due to the large 
number of wells involved. 
An even more rapid technique (within a week) of monoclonal antibody production can be 
performed with flow cytometry, PCR, and next generation sequencing. Following B cell 
isolation via flow cytometry, single B cells can be isolated in microwells embedded on a slide, 
and PCR primers (each specific for heavy and light chain genes) are used to construct a single 
DNA fragment that consists of both heavy and light chain genes. Recovered DNA strains are 
then analyzed with next generation sequencing to identify unique heavy and light chain pairs, 
and sequences that are most appropriate to develop a recombinant antibody are determined. 
Although this method can be performed in a week, the microwell slides are not commercially 
available, and data analysis typically requires extensive bioinformatics knowledge (DeKosky et 
al., 2013; Zeliadt, 2014). 
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The genetic regions that are responsible for the complementary determining regions of an 
antibody can be rearranged to become more specific for a particular antigen to create 
recombinant antibodies. Following genetic alterations, the antibodies that are most specific for 
the antigen can be selected for and isolated. These complementary determining regions can be 
paired with the constant portion of an antibody, thus providing an antibody with a specific target 
and functionality (Waltz, 2006). 
Regardless of the antibody source, after collecting a pool of polyclonal antibodies, a 
researcher is often left with antibodies that may or may not be sufficient for a particular 
application. Developing methods to sort out and identify the interaction each polyclonal antibody 
has with the respective antigen is a critical step in taking advantage of a source of antibodies. 
Protein microarray systems have been investigated as means for screening a large number of 
antigens to determine which antigen(s) an antibody will best recognize (most sensitive and 
specific) (Lee et al., 2012; Yu et al., 2013). Also, a protein microarray can be used to determine 
the affinity of an antigen against a library of antibodies (Rivas et al., 2008; Ferreira and Finlay, 
2012). These methods will potentially be useful in vaccine and cancer research (Yu et al., 2013), 
as well as in other areas where the affinity of a large number of antigens or antibodies needs to 
be characterized. 
For example, a method known as in vivo-induced antigen technology (IVIAT) has been 
used to detect antigens in the human gastrointestinal tract. The IVIAT approach was performed 
by John et al., (2005) to reveal the virulence of E. coli O157 by determining which proteins of E. 
coli O157 are expressed during human infection (John et al., 2005). These authors identified two 
hundred and twenty three proteins that were expressed during human infection of E. coli O157, 
some of which were not accounted for upon analysis of a mid-exponential phase E. coli O157 
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culture. These authors suggest these in vivo-induced (ivi) proteins could provide insight to 
human infection caused by E. coli O157, and be appropriate targets for detecting E. coli O157 in 
stool specimens. As protein detection systems become more sophisticated, virulence 
mechanisms, as well as the most relevant antigens will likely be revealed. 
Since protein microarrays are useful for determining the antigen that an antibody is most 
compatible for, an antibody can be screened against a library of antigens (or vice versa), and 
depending on the amount of antibodies/antigens that are available, highly sensitive and specific 
antibodies can be isolated and used in other immuno-based detection assays. Antibodies of non-
animal origin or from hen eggs could be used to screen numerous antigens of interest, and 
eventually collect a set of useful antibodies. 
Progress toward alternative antibody production could lead to a supply of more reliable 
and feasible antibodies. If such alternatives were proven to be equivalently reliable as previous 
methods, novel antibody production methods could become the preferred method of antibody 
production. As new antibody development techniques surface, researchers can implement such 
techniques for creating an antibody most fit for the application in mind (Berghman et al., 2005). 
Compared to conventional methods, alternative methods may provide more rapid 
antibody production. In addition to more readily available antibody sources, these methods and 
BLAST will ultimately result in a library and unlimited supply of antibodies that can be used to 
target the nested epitope sequences of relevant pathogens. As technology progresses, developing 
alternative methods will likely provide much greater flexibility in the antibody construction 
process. 
 
Advances in capture antibody systems 
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A generic capture antibody could initially be used to detect and recover all E. coli with an 
available sorting system such as FACS. The antibody would need to target only one site of an E. 
coli extracellular protein – an antibody of single specificity will be necessary to ensure two 
events are not counted where only one E. coli actually exists in a sample. In a similar theory to 
the BAX system, antibodies congruent with unique fluorescence that are specific for each 
serogroup could be applied to determine which serogroups were present in the sample. 
Multifluorescent analysis is becoming more advanced (Baumgarth and Roederer, 2000; 
Herzenberg et al., 2002; De Rosa et al., 2003; Perfetto et al., 2004), and with an available generic 
antibody, such methods could be integrated into detection. Upon the initial sorting and 
acquisition of a generic E. coli population, one could detect the “big six” via flow cytometry with 
six available fluorescent markers that aligned with each serogroup. This procedure would only be 
applicable with flow cytometers that contained more than one laser. If six distinguishable 
markers were not readily available, two markers (each specific for three of the “big six”) could 
be used and would also make sorting capabilities less complex. Following the secondary flow 
cytometry analysis and sorting process, IMS could be applied to samples that were positive for 
respective serogroups. Afterward, culture and identification could be performed as currently 
practiced. Cross-reactivity of antibodies and protocol accuracy would need to be investigated and 
addressed prior to becoming implemented in the food industry. If deemed as being acceptable, 
optimized flow cytometry protocol(s) could reduce the duration of the test and hold procedure 
and accelerate food distribution without compromising product safety. 
 
Conclusions 
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There will likely always be a strong push to create and optimize highly sensitive 
detection methods for use in food systems associated with low infectious dose pathogens such as 
STEC (Palumbo et al., 1997). Correctly and consistently identifying these harmful bacteria is 
important due to significant health and economic implications that can result from illnesses. 
More efficient assays (shorter time-to-results, increased accuracy, and minimal preparation 
and/or labor) would accurately guide outbreak investigations and provide the food industry 
confidence that products are safe.  
Detection methods were developed for E. coli O157:H7 once it was considered an 
adulterant, and with the emergence of regulations for the “big six” such methods only targeting 
E.coli O157:H7 are no longer applicable. With increased diversity in serotype prevalence, 
continued public reaction, and corresponding government action, current protocols considered 
efficient for regulatory purposes will need to be altered more frequently to account for new 
serotypes, leading to the need for new approaches or adjustments to satisfy new food safety 
standards. The USDA-FSIS has provided considerations and suggestions for assay validation to 
become equal in the eyes of current regulations and requirements (FSIS, 2010). When 
developing protocols it should be kept in mind that emerging pathogens and the possibility for 
them to interfere with food safety regulations can occur and requires strategic efforts to create 
assays adaptable to new serotypes. Also, declaring samples as presumptive positives only if both 
stx and eae genes are present may need to be reconsidered. There have been instances of STEC 
causing human illness that do not possess eae (Paton et al., 1999; Eklund et al., 2001; Willford et 
al., 2009). If PCR were the only method used for testing, STEC lacking eae could potentially 
lead to false negative results and undetected risk coming through the food supply system. An 
increase in outbreaks due to eae-negative STEC would likely lead to restructuring of current 
  
103
detection requirements and initiate the edict that samples positive for the stx or eae genes would 
need to be considered as presumptive positives. As more STEC become associated with illness, 
development of PCR primers specific for these STEC will be in demand (Auvray et al., 2007; 
Fratamico and Bagi, 2012). 
In addition to the need to develop assays adaptable to new serotypes, such assays should 
have a broad application to many food systems that have been and could potentially become 
associated with STEC and foodborne pathogens in general. Unforeseen obstacles have risen and 
are likely to continue in the future for detection systems due to the physiological elusiveness of 
STEC and their ability to adapt and either not code the usual virulence gene(s) or implement 
similar virulence factors with different genes and cause illness. 
For example, a serotype never before known to cause infection in humans resulted in a 
2011 outbreak in Northern Germany. E coli O104:H4 was the causative agent, and the isolate 
had acquired both a phage encoding the stx gene and a plasmid containing EAEC virulence 
genes. The outbreak was unfortunate in that an uncharacteristically high percentage (25%) (Zhao 
et al., 2011) of illnesses progressed to HUS, more so than usual (5%) (Tuttle et al., 1999). It has 
been hypothesized such an increase in HUS cases was due to the acquired EAEC virulence 
factors that aided in the uptake of the Stx (Muniesa et al., 2012). The ability of E. coli O104:H4 
to form such uncharacteristic modes of virulence is a troublesome reality in epidemiology, and 
there are concerns that comparable adaptations will occur and result in similar outbreaks 
(Chattaway et al., 2011). Such instances of gene transfer via plasmids (Ogura et al., 2009) and 
phages (Muniesa et al., 2003, 2004) to E. coli contribute to the virulence of pathogenic E. coli. 
Such situations are a major threat to public health due to the possibility that the current detection 
methodologies will not be applicable for emerging serotypes (Wang et al., 2013). 
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The evolution of methods with increased sensitivity will likely continue as it has in the 
past due to consumer demand, as well as threats of bioterrorism (Sobel et al., 2002). Although 
certain methods may be highly accurate, their chance of being implemented into clinics and the 
food industry is hindered by the difficulty to perform these methods by clinicians and laboratory 
technicians. Creation of protocols that can be performed with minimal training will be an asset to 
the food detection systems. The cost to train lab technicians on specific protocols also needs to 
be considered (Hoorfar, 2011).  
Implementing a new pathogen detection method in the food industry is a complex issue 
for several reasons. The efficiency of an assay can vary depending on the type of food and its 
components, so protocols need to be specific for food types and be validated when applied to 
untried food systems (Hoorfar, 2011). It is also possible that assay efficiencies will differ in 
similar foods due to the ingredient type and even quality. The age and concentration of organic 
molecules or electrolytes can vary in meat products and in turn alter the function of an assay (Fu 
et al., 2005). To our knowledge, the quality of food ingredients and the effects on detection 
capabilities has not been investigated in immuno-based and flow cytometry protocols. It might 
be worthwhile to investigate how the grade and quality of a food affects detection sensitivity 
while detection protocols are being developed for food systems. It is possible that a highly 
efficient assay not known to produce false negatives may not apply to food systems that 
extensively vary in quality and composition. If a new system were to be introduced to the food 
industry, knowing any quality limitations would be important, especially in production facilities 
characteristic of product diversity. One can gauge the efficiency of an assay for new products 
based on the assay performance in a similar food system, but a confirmation analysis will be 
necessary. 
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When discussing detection methods several terms are commonly used with regard to 
analyzing results. Readers should take caution when using these terms and acknowledge the 
author’s reference point. Accurate, efficient, rapid, specific, sensitive, quick, and simple are 
terms that are frequently encountered descriptions of flow cytometry and immunoassay methods 
when discussed in the published literature. When it is stated that an assay is “rapid” or “simple”, 
one must realize that this may refer to a specific portion of the protocol, and does not necessarily 
account for the steps to prepare for the assay. For example, incubation and wash steps during an 
ELISA assay, the practice of follow-up or conformation PCR assays, and sample preparations 
such as DNA extraction for PCR or removing concentrated food constituents should be 
considered. Immunoassays will continue to be applicable as antibodies are further characterized 
(Skinner et al., 2013). As STEC evolve and serotypes become associated with human infection 
and food products, the need for antibodies in these detection systems will benefit human health 
and the food industry. If available tools such as organism search engines (BLAST) and antibody 
production alternatives (in vitro, IgY production from hen eggs, among others) continue to 
emerge and become applicable, researchers can potentially keep pace with what is needed for 
detecting new serotypes by immuno-based methods. 
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Table 1. Monoclonal and Polyclonal Advantages and Limitations 
 Monoclonal Polyclonal 
Advantages Unique/single epitope specificity Multiple epitopes for an antigen 
 Large quantities can be acquired Epitope rearrangements/mutations less likely a problem due to 
 Uniformity among batches    multiple epitope targets^# 
  Relatively short production period (4 to 8 weeks) 
  More stable and less sensitive to pH and salt concentration 
     fluctuations# 
   
Limitations Only applicable for detecting one epitope Wider antigen specificity (similar protein and sugar antigens 
 Possible false negatives from epitope    among nontarget bacteria can result in false positives@ 
    rearrangement/mutation* Batch-to-batch variation^ 
 Time consuming (3 to 6 months)^#  
 Rarely precipitate antigen (one binding site  
    limits cross-linking abilities  
 #  Lipman et al., 2005  
 ^  Leenaars et al., 1999  
 *  Herzenberg, Sweet, & Herzenberg, 1976  
@ Fukal & Káš, 1989  
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Table 2. Flow Cytometers   
Instrument Laser (nm) Reference 
Beckman Coulter FC500 488, 633 Hegde et al., 2012b 
BD Bryte HS Instrument (BioRad Laboratories) 470-490 Tortorello et al., 1997 
FACSCalibur (BD, Sydney, Australia) 488 Gunasekera et al., 2003 
FACSStar + (BD, San Jose, CA) * Bernander et al., 1998 
EPICS Elite (Beckman Coulter, Fullerton, CA) 488 Yamaguchi, 2003; Tortorello et al., 1997 
LSR Flow Cytometer (BD) * Zumbrun et al., 2013 
Argus 100 (Skatron Lier, Norway) * Bernander et al., 1998 
RAPID-B model 9013 (LITMUS RAPID-B) 488 Wilkes et al., 2012 
BD FACScan 488 Riedy et al., 1991  
* Multiple lasers   
BD - Becton Dickinson   
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Table 3. Terminology   
Sensitivity probability that a positive sample will be screened as negative (positive 
 samples that are determined "positive" are known as false negatives)* 
Specificity probability that a negative sample will be screened as negative (negative 
 samples that are determined "positive" are known as false positives)* 
* FSIS, 2010  
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Introduction 
Although there are forms of Escherichia coli which reside in the intestinal tract of 
humans as commensal microorganisms, a certain subtype (enterohemorrhagic E. coli (EHEC)) of 
pathogenic E. coli known as Shiga toxin-producing E. coli (STEC) produce shiga toxin(s). Shiga 
toxin-producing E. coli are considered to be a high-risk to humans due to the low infectious dose 
that can result in foodborne illness. Additionally, ill persons infected with EHEC pathogens can 
develop a disease known as hemolytic uremic syndrome (HUS), which can be fatal, especially in 
children and the elderly (Tarr et al., 2005; Mayer et al., 2012). 
Major concerns have resulted from the emergence of the E. coli O157:H7 serotype 
(Armstrong et al., 2006), and more recently the non-O157 serogroups (commonly referred to as 
the “big six” (serogroups O26, O45, O103, O111, O121, and O145)), which are all considered 
adulterants in raw non-intact ground meat (Fratamico and Bagi, 2012; FSIS, 2014a,b). Outbreaks 
and recalls have been frequently associated with these STEC throughout the past decades, 
resulting in commercial economic loss, illness, and possibly death (CDC, 2014a, b). More 
sensitive and specific STEC detection assays continue to be investigated, and optimization of 
these assays will be advantageous to the food industry and consumers to limit recalls and 
foodborne illnesses, respectively. 
The USDA recommends the practice of PCR (BAX®) for detecting O26, O45, O103, 
O111, O121, and O145 serogroups (FSIS, 2014a, b), which is typically preceded by a lengthy 
and necessary enrichment step. Quantitative PCR (qPCR) assays are useful for enumerating cell 
populations in a sample (Smith and Osborne, 2009), and this method has previously been utilized 
for STEC detection (Debroy et al., 2004, 2005; Fratamico et al., 2005, 2011, 2012). Quantitative 
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PCR assays can be advantageous since analyses provide an approximate enumeration of the 
target organism(s) in samples, and yields a more in-depth analysis (quantification) opposed to 
conventional PCR platforms that simply provide a presence/absence analysis. 
In addition to PCR assays, future commercial detection procedures may integrate 
immuno-based detection systems (Baker et al., 2015). Flow cytometry continues to be optimized 
for detection strategies, and these platforms are beneficial due to the potential for automation as 
well as a shortened time to results (Hegde et al., 2012a, b; Buzatu et al., 2014; Wilkes et al., 
2012; Beers et al., 2015). For instance, a flow cytometry assay (RAPID-B®) was recently 
compared to the BAX® system, and in addition to showing parallel results, this method was 
performed in a mere 8 h (Beers et al., 2015), which provides the opportunity for large scale 
sample analysis, especially if several instruments were utilized simultaneously. 
Commercial laboratories may utilize a variety of detection assays, and it is difficult to 
directly compare different nonculture-based rapid detection systems (flow cytometry versus gene 
amplification) in food matrices since these systems focus on distinct microbial cell components 
(protein antigen versus molecular, respectively). Regardless of the assay(s) that becomes (or 
continues to be) commonplace in large-scale commercial pathogen detection procedures, having 
stocks of absolute and known quantities of cells could be useful as an internal standard positive 
control for periodic instrument and assay validation. Utilizing versatile and universally accurate 
internal standards that complement a broad range of multiple and different assays, whether 
molecular or immuno-based, would be beneficial for pathogen detection laboratories and large-
scale commercial operations where routine detection assays are conducted. 
Bacterial cell fixation provides a means to obtain a stabilized bacterial cell population 
that could be advantageous as an internal standard – fixatives help maintain cell structure, 
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permeabilize cells (which enhances accessibility of antibodies with their target(s)), and terminate 
the biological mechanisms of cells. This provides a means to revisit samples at a later date and 
determine their properties at the time of fixation (Bongaerts et al., 2002). An internal standard is 
commonly used to adjust and calibrate instruments in analytical chemistry, and provides 
appropriate measurements in conjunction with samples to obtain a more reliable data set (de 
Oliveira, 2010). Formalin-fixed cells would provide a calibration technique similar to an internal 
standard by yielding a positive control that can be used to quantitatively assess and compare with 
food or environmental subsamples. These procedures may also save time and increase laboratory 
safety measures (Bongaerts et al., 2002) by eliminating the need to repeatedly enrich/culture 
pathogens, extract DNA, and perform serial dilutions for calibration. Additionally, these 
procedures may reduce labor requirements and further support automation for foodborne 
pathogen detection.  
In this study we present an alternative method that utilizes formalin-fixed STEC cells for 
standard curve development for different quantitative assays that can potentially be incorporated 
into commercial operations. Several detection instruments can be calibrated with the same set of 
fixed cells, which will provide a baseline and more uniform positive control for detection assays. 
The objective of this study was to compare fixation methods (8% versus 10% formalin-fixative) 
with BAX® PCR, qPCR, and flow cytometry platforms, as well as determine the recovery rate of 
spiked cells in ground beef for STEC serotypes O26:H11, O45:H2, O103:H3, O111:H-, 
O121:H19, and O145:H18 with quantitative PCR and flow cytometry assays. 
 
Materials and methods 
Escherichia coli strains, culturing conditions, and cell preparation 
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Strains used in this study are listed in Table 1. Isolated colonies from each STEC 
serotypes were inoculated in 10 mL of Luria-Bertani (LB) Broth and incubated at 37°C for 24 h 
to obtain overnight cultures. All overnight cultures were centrifuged (5 min, 8,000 x g) with an 
Avanti J026 XP centrifuge in a JA-17 rotor (Beckman Coulter, Inc. Brea, CA, USA). Following 
centrifugation, the supernatant was discarded, and the cell pellet was stored until fixation. 
 
Cell fixation 
An overnight culture of each STEC serotype (O26:H11, O45:H2, O103:H3, O111:H-, 
O121:H19, and O145:H18) was obtained as previously described, and the cells were subjected to 
10 mL of fixative. Cell pellets were resuspended in 10 mL of fixative, and the cells were 
incubated at room temperature for 30 minutes with periodic vortexing. Fixed cells were 
centrifuged (5 min, 8,000 x g) and washed twice with PBS (pH 7.4) before being resuspended 
with PBS. A previously published fixative procedure (8% formal-saline) (22-24) as well as a 
commercial fixative (10% formalin-fixative) (Sigma-Aldrich® Formalin Solution 10%, Neutral 
Buffer, St. Louis, MO) was evaluated for each STEC serotype. 
 
Approximation of STEC serotype cell concentrations – Phase Contrast Microscopy 
Cells of each respective STEC serotype (O26:H11, O45:H2, O103:H3, O111:H-, 
O121:H19, and O145:H18) were enriched, fixed, and washed as previously described, and the 
concentration of each STEC serotype (for each fixation method) was approximated in a Petroff-
Hausser Bacteria Counter (1/400 Sq. mm, 1/50 mm deep, C. A. Hausser & Son, Phila., PA, 
USA) under oil immersion (1000 X magnification) with a Nikon Phase Contrast microscope 
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(Nikon Inc., Tokyo, Japan). For each cell suspension, sixteen squares in total were counted and 
averaged, and the following equation was used to approximate each cell concentration: 
cells/mL = (average cells/square) / 5 × 10-8 
 DNA extraction 
 Prior to all PCR reactions, DNA was extracted from samples (1 mL) with a Qiagen 
DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA, USA) according to the instructions of the 
manufacturers. 
 
BAX® PCR 
A single colony of each respective STEC serotype (O26:H11, O45:H2, O103:H3, 
O111:H-, O121:H19, and O145:H18) was inoculated into 5 mL TSB broth, and incubated at 
37°C for 18 to 24 h. Following enrichment, cells were fixed and washed as previously described. 
Fixed cells were subsequently diluted, and various concentrations of fixed cells (8 and 10% 
formalin fixatives) for STEC serotype were analyzed by BAX® PCR according to the 
instructions of the manufacturers (DuPont, 2013) to compare fixatives, as well as determine the 
limit of detection for both assays. 
 
Quantitative PCR standard curve generation and conditions 
The standard curve was generated for each STEC serotype by determining the genome 
size and copy number of the respective STEC serotypes. Standard curve dilutions were 
performed with nuclease free water (Integrated DNA Technologies, Coralville, IA, USA). All 
qPCR experiments (standard curves and samples) were performed in triplicate, as well as in 
conjunction with melting curve analysis. The qPCR reaction mixtures consisted of 5 μL of DNA, 
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500 nM of each primer (Table 2), 10 μL of SYBR® Premix Ex Taq™ II (Takara Bio, Inc., Shiga, 
Japan) and nuclease free water to bring the final reaction volume of 20 μL. Quantitative PCR 
reactions were performed as follows: 95°C for 2 min, and 40 cycles of 95°C for 15 s, annealing 
at 60°C for 15 s, extension at 68°C, followed by a melting curve analysis consisting of an 
increasing temperature of 0.5°C per min for 20 min from 60°C to 95°C. All analyses were 
performed with a standard curve simultaneously in triplicate.  
 
Spiking ground beef samples 
Following fixation and approximation of STEC serotype cells, the cells were diluted ten-
fold, and the various cell concentrations were spiked in ground beef samples. One mL of each 
fixed cell dilution for each STEC serotype was inoculated in 25 g ± 1 g of commercially 
irradiated ground beef in a stomacher bag, and incubated at room temperature for 10 min. 
Following incubation, 225 mL of mTSB + novobiocin (8mg/L) (Modified Tryptone Soya Broth, 
Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) was added to the spiked ground beef and 
stomached for 2 min after which subsamples (1 mL) were obtained for DNA extraction and 
qPCR. 
 
Flow cytometry analysis of fixed cells 
 The fixed cells that were spiked into ground beef samples and evaluated by qPCR were 
analyzed via flow cytometry with the RAPID-B® model 9013 flow cytometer (Vivione 
Bioscience, LLC, Pine Bluff, AR). One mL of sample was filtered (5.0 μM), and 100 μL of 
filtered sample was incubated with PBS, Reagent B, and antibodies (total volume 1 mL) from the 
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Non-O157 STEC Test Kit (Vivione Biosciences, LLC) for 25 min, and samples were evaluated 
on the RAPID-B® platform according to the instructions of the manufacturers. 
 
Statistical analysis 
 The coefficient of variation for STEC serotypes was determined for the quantitative PCR 
cell recovery of ground beef spiked samples. All statistical analyses were performed on log 
cells/mL inoculated in ground beef, which was evaluated with a single factor one-way ANOVA 
test (P ≤ 0.05) in Microsoft Excel® (Microsoft Corporation, Redmond, WA). 
 
Results 
BAX® PCR, fixed cell comparison, and limit of detection 
Cells were subjected to each fixative and subsequently analyzed by PCR (BAX® Real 
Time (Dupont, 2013)) as recommended by USDA (FSIS, 2014a, b). The average limit of 
detection among 10% and 8% formalin-fixed cells was determined to be 488 and 3,821 cells/mL, 
respectively. 
 
Comparison of 8 and 10% formalin fixative methods by qPCR 
The cell concentration for each sample analyzed (excluding serotypes O45:H2 and 
O145:H18) was higher for 8 versus 10% fixed cells (Table 3), yet the cycle threshold value for 
8% formalin-fixed cells was higher among all serotypes tested. 
  
Spiked ground beef cell recovery and limit of detection 
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The average percent cell recovery exceeded 100% (an overestimation of copy number) 
for ground beef samples spiked with serotypes O26:H11 (107 ± 11%), O45:H2 (101 ± 5%), 
O103:H3 (108 ± 6%), and O145:H18 (107 ± 3%), and serotypes O111:H- and O121:H19 
exhibited a recovery level lower than 100% (97 ± 6% and 95 ± 16%, respectively) (Table 4). The 
average limit of detection for the STEC fixed cells was determined to be 272 ± 342 cells/g 
(average ± standard error) of ground beef. 
 
Flow cytometry detection and analysis of fixed cells 
 Spiked ground beef samples containing fixed cells were analyzed with the RAPID-B®. 
Assays designed to enumerate STEC serogroups in ground beef following an enrichment step 
have been utilized (Buzatu et al., 2014). The samples containing STEC fixed cells without 
enrichment were subjected to the antibodies specific for STEC serogroups O26, O45, O103, 
O111, O121, and O145. Total events for trial 1 samples were roughly a log lower for each 
serotype when compared to the cells/mL approximation with phase contrast microscopy as well 
as the quantitative PCR evaluations (Table 5). In general, trial 2 samples exhibited similar 
(within a log cells/mL) cell number analyses in comparison with the phase contrast cell 
approximation and quantitative PCR evaluations (Table 5). 
 
Comparison of different approximation and quantitation techniques 
 A single factor one-way ANOVA analysis (P ≤ 0.05) was performed to compare the 
approximation of log cells/mL by phase contrast microscopy with the quantitation of log 
cells/mL by flow cytometry and quantitative PCR methods, and the results were not considered 
statistically significant. 
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Discussion 
Flow cytometry can provide a means of rapidly analyzing a large amount of samples (100 
to 1000 samples per day) with limited user assistance or automation, and commercial detection 
kits (antibodies, reagents, among others) may incorporate various stock concentrations of fixed 
cells to complement a wide range of assays. This will provide internal positive control sample 
volumes to calibrate as well as validate protocols. To our knowledge, fixed cells have not been 
incorporated into a qPCR assay, and similar stock concentrations of fixed cells would 
supplement qPCR by negating the enrichment of isolated colonies for standard curves used in the 
assay. 
 For the quantitative PCR assays, there were several instances of underestimation of cell 
number, which could be problematic if the goal of a qPCR assay was to enumerate absolute 
counts of a STEC serotype in a sample, but since certain STECs are adulterants (Fratamico and 
Bagi, 2012), the qPCR methods described here would be sufficient for a reliable 
presence/absence assay. Decreased sensitivity is an issue in high fat or protein food matrices, 
which can affect amplification efficiency and primer binding to the target template (Yeni et al., 
2014). 
Overestimation of cells is likely due to the fact that the standard curve was based on copy 
number and genome size of each serogroup. It is generally assumed that one copy (a single gene 
product) is equivalent to one cell, but it has been suggested that the genome size can vary among 
a population of cells (Bignell et al., 2004; Li and Olivier, 2012). If a cell population were fixed in 
the process of continued growth, it is possible that a single fixed cell could constitute multiple 
partial chromosomes (Li and Olivier, 2012), in which gene copy number would possibly not 
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correlate with absolute cell number. Detection capabilities of molecular methods such as qPCR 
are food and microorganism dependent (Yeni et al., 2014) – optimizing these assays for many 
different food matrices can be laborious and time consuming, and a beneficial standard stock of 
fixed cells may provide a means to optimize detection assays in a more timely and feasible 
fashion. Additionally, obtaining a more precise copy number from fixed cells may be possible 
with a continuous culture system, which during steady state at a set cell division would provide 
synchronized cell populations that could be used over a long duration of time (Yaginuma et al., 
2014).  
The flow cytometry assay used in this research was modified from the manufacturers 
procedures in that 225 mL of broth was used to simulate enrichment (75 mL of broth is 
recommended in the protocol). There were several instances of underestimation of cell number 
for the assay performed, which can result from inhibitory effects of fats present in the ground 
beef samples. 
Developing a reliable internal standard with fixation methods will provide a means of 
reliably calibrating pathogen detection instruments periodically. For food quality control 
personnel, conducting assays on a variety of platforms as well as having a reliable internal 
standard would be beneficial for sample testing when compared to other methods that go through 
steps of isolation, enrichment, and DNA extraction prior to the development of a standard curve 
template. Of particular importance is the availability of stable intact bacterial cells that can be 
used for diverse detection methods that involve identifying intact cells with consistent antigen 
presentation in immuno-based methods, or as an extraction source of DNA for molecular 
techniques. Fixed cell standards could be used for on-site applications for transportable assays, 
  
135
135
and the same set of fixed cell standards could be used throughout different laboratories for a 
more uniform and homogenous calibration protocol. 
It is possible that STEC fixed cells bind to various components in ground beef or be non-
randomly distributed, which could also play a role in not recovering 100% of cells. The extent to 
with fixed cells interact with these components warrants further investigation. Fixative 
procedures have been implemented in several instances. Chao and Zhang (2011) investigated 
fixation methods to study cell morphology and structure of Bacillus subtilis, Escherichia coli, 
and Pseudomonas putida by atomic force microscopy. These authors concluded that the most 
effective fixative for these microorganisms was 2.5% glutaraldehyde. The effects of fixation on 
bacterial structure and outer membrane integrity have been investigated, but it seems very few 
questions have been addressed with regard to how fixation procedures effect detection of 
microorganisms. Kamiya et al., (2007) investigated fixed marine bacteria and how storage time 
compromised quantitative assays via flow cytometry. These authors determined that their 
fixation procedure did not affect bacterial counts but that an increased storage time did have an 
effect on enumeration procedures via flow cytometry (Kamiya et al., 2007). 
Storing samples for an extended amount of time could potentially impact detection 
efficacy. Gasol and Del Giorgio (2000) suggested that fixatives could be implemented prior to 
flow cytometry assays to preserve planktonic bacteria that cannot be evaluated immediately once 
samples are freshly processed. Similar methods could be used to evaluate foodborne pathogens 
in food or for on-site sampling. 
Initial fixation with formaldehyde limits autolysis of cells (Kiernan, 2000), and reacts 
with proteins, lipids, and nucleic acids (French and Edsall, 1945; Hopwood, 1969). The protein-
formaldehyde interaction provides the opportunity for additional protein(s) to interact with the 
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end group of the formaldehyde-bound protein and if these two reactive end groups are within 
close enough proximity to one another, a cross-link (methylene bridge) may form (Kiernan, 
2000; Dapson, 2007). Formaldehyde fixatives interact with biological molecules to form what 
has been referred to as addition products, which are reactive and have the potential to crosslink 
the end groups of other molecules (Dapson, 2007). Several fixatives have been utilized for a 
wide range of purposes, and the most appropriate fixative is application and objective-dependent 
(Hopwood, 1969; Fox et al., 1985). 
A primary advantage of fixing cell concentrations for a positive control is to avoid 
fluctuations in cell populations, which can occur over time in populated cells. It has been 
suggested that fixation can influence cell structure and morphology (Chao and Zhang, 2011), and 
although this may lead to changes that negatively impact antibody-based detection strategies, 
many of the detection analyses may not require absolute cell concentration analysis, and a rough 
estimate of cell number in a sample may suffice. An internal standard detection method may 
limit overall detection time by eliminating the need to enrich cells and DNA extraction for 
creating genomic DNA-based standard curves. Additionally, these methods may limit risk and 
result in a safer working environment by limiting hands-on applications with live STEC cells. 
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Table 1. Shiga toxin-producing Escherichia coli strains used in this study 
Serotype ID Source Reference 
O26:H11  05-6544 human National Microbiology Laboratory 
O45:H2  05-6545 human Nova Scotia Public Health Lab 
O103:H3  E67 cattle Francisco Diez-Gonzalez 
O111:H-  JB1-95 Mettwurst (fermented sausage) Australia outbreak, 1995 
O121:H19  03-2832 human Alberta Public Health Lab 
O145:H18  03-4699 human Alberta Public Health Lab 
  142
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Primers used in quantitative PCR assays    
Serogroup Sequence Gene Product Reference 
O26 TAAATTGCGGGGAAAGAATG wzy 276 (10) 
 GACTTCATGGGTACCGCCTA    
O45 TATGACAGGCACATGGATCTGTGG wzx 255 (11) 
 TTGAGACGAGCCTGGCTTTGATAC     
O103 TTGGAGCGTTAACTGGACCT wzx 321 (12) 
 GCTCCCGAGCACGTATAAAG    
O111 TGTTCCAGGTGGTAGGATTCG wzx 237 (13) 
 TCACGATGTTGATCATCTGGG    
O121 AGGCGCTGTTTGGTCTCTTAGA wzx 189 (13) 
 GAACCGAAATGATGGGTGCT    
O145 AAACTGGGATTGGACGTGG wzx 135 (13) 
 CCCAAAACTTCTAGGCCCG    
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Table 3. Quantitative PCR Ct value of 8% and 10% formalin fixed cell for STEC serotypes 
 O26:H11, O45:H2, O103:H3, O111:H-, O121:H19, O145:H18 
   
Cells/mL 106 105 104 
  10% 8% 10% 8% 10% 8% 
O26:H11 20.90 ± 0.09a 22.26 ± 0.12 24.30 ± 0.16 25.56 ± 0.14 27.44 ± 0.19 29.12 ± 0.36 
O45:H2 17.07 ± 0.09 19.20 ± 0.08 21.24 ± 0.16 23.19 ± 0.07 24.54 ± 0.07 27.22 ± 0.09 
O103:H3 20.51 ± 0.05 24.27 ± 0.27 24.11 ± 0.11 27.12 ± 0.07 27.39 ± 0.23 30.53 ± 0.42 
O111:H- 22.89 ± 0.16 22.75 ± 0.14 26.69 ± 0.09 25.88 ± 0.40 29.50 ± 0.11 29.86 ± 0.73 
O121:H19 19.74 ± 0.12 23.42 ± 0.12 23.18 ± 0.15 26.67 ± 0.07 26.12 ± 0.29 30.43 ± 0.14 
O145:H18 20.24 ± 0.09 25.92 ± 0.10 23.81 ± 0.07 30.22 ± 0.11 27.12 ± 0.20 33.40 ± 0.34 
  103 102 
  10% 8% 10% 8% Efficiency (%) R2 
O26:H11 31.53 ± 1.31 32.04 ± 0.30 ND 36.39 96 0.993 
O45:H2 29.38 ± 0.25 30.48 ± 0.55 32.30 ± 0.75 35.38 ± 2.15 91 0.987 
O103:H3 30.42 ± 0.22 32.85 ± 0.23 33.78 ± 0.28 34.23 89 0.997 
O111:H- 32.23 31.5 ± 0.91 35.62 ± 0.37 35.39 ± 0.19 96 0.997 
O121:H19 29.85 ± 0.59 34. 82 ± 0.51 32.27 ± 0.81 35.93 ± 2.41 92 0.993 
O145:H18 30.46 ± 0.15 NDb 32.84 ± 0.60 ND 97 0.99 
 avalues represent Ct value ± SD 
 bND denotes not detected 
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Table 4. Quantitative PCR recovery of STEC fixed cell 
Serotype Average cell recovery (%) CV# (%) 
O26:H11  107 ± 11 10.36 
O45:H2  101 ± 5 5.24 
O103:H3  108 ± 6 5.97 
O111:H-  97 ± 6 5.93 
O121:H19  95 ± 16 16.82 
O145:H18  107 ± 3 3.16 
#CV denotes the coefficient of variation (CV = standard deviation: average x 100)   
*Limit of detection among all serotypes 272 ± 342 cells/g 
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Table 5. Log cells/mL evaluation with phase contrast microscopy, flow cytometry, 
 and quantitative PCR 
  Log cells/mL 
Trial 1 Trial 2 
Serotype PC FC  qPCR PC FC  qPCR 
O26:H11  5.60 4.51 5.04 6.43 6.25 6.41 
4.60 3.48 4.85 5.43 5.16 5.18 
3.60 2.62 3.97 4.43 ND 4.51 
O45:H2  6.49 5.77 6.24 6.20 6.70 6.49 
5.49 4.65 5.55 5.20 5.38 5.31 
  4.49 4.88 4.40 4.20 4.40 4.22 
O103:H3 5.90 4.84 5.38 6.11 5.91 6.49 
4.90 3.85 4.50 5.11 4.88 5.39 
3.90 2.99 5.61 4.11 3.78 4.56 
O111:H-  6.58 5.67 6.44 6.34 6.29 6.12 
5.58 4.75 5.39 5.34 5.20 5.21 
  4.58 3.73 4.79 4.34 4.23 4.13 
O121:H19  6.62 4.73 4.91 6.18 6.54 6.63 
4.62 3.60 3.97 5.18 5.16 5.37 
3.62 3.26 3.04 4.18 4.40 4.42 
O145:H18  6.28 5.48 6.32 6.23 6.50 6.30 
5.28 4.52 5.31 5.23 5.27 5.25 
  4.28 3.54 4.39 4.23 4.11 4.21 
*Three ten-fold dilutions for each serotype were evaluated for each detection method   
PC - Phase contrast microscopy for cell approximation 
FC - Flow cytometry (RAPID-B®) 
qPCR - quantitative PCR 
ND – not detected 
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IV. Conclusion 
Pathogenic E. coli known as Shiga toxin-producing E. coli (STEC) have been and 
continue to be associated with various food products including ground beef. The regulatory 
requirements and the adulterant status of several STEC serogroups should be considered for 
assay development and improvements, and as certain STEC serogroups become more prevalent 
these will also likely become declared adulterants. Molecular assays continue to be the primary 
means of STEC detection, and immuno-based detection methods have also gained considerable 
attention for future developments. Optimizing detection methods in foods have been focused on 
more prompt and accurate analysis. Immunoassay antibody capture systems and flow cytometry 
platforms have been implemented into several food-based detection systems. By applying 
antibodies that will interact with target microorganisms, immunoassays can be used to directly 
detect and quantify pathogens. Immuno-based protocols could potentially be further 
implemented into the food industry, limit the duration of the detection process, and increase 
accuracy. Several STEC are considered adulterants in raw, non-intact ground meat, and several 
detection assays for these microorganisms have been investigated. The objective of the research 
in this thesis was to determine the efficacy of formalin-fixed STEC cells as a potential means to 
calibrate various detection assays. Eight and ten percent formalin-fixed cells were compared with 
quantitative PCR (qPCR), and the results suggest that the ten percent formalin fixed cells were a 
more sufficient means to quantitative cell populations. These results were based on the 
approximation of cells/mL by means of phase contrast microscopy. Fixed cells were spiked into 
ground beef samples, and the recovery rate for each STEC serotype was determined by qPCR. 
Additionally, the log cells/mL of spiked samples were determined by qPCR and flow cytometry. 
The log cells/mL evaluated for each assay were determined to not be statistically significant, 
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which suggests that formalin fixed cells could be used across a wide range of detection platforms 
(immuno-based versus molecular). Commercial detection kits could potentially implement 
formalin-fixed cells as a more standardized positive control to calibrate detection platforms 
simultaneously as well as among laboratories. 
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